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Abstract
This dissertation contains two types of population models with applications in
conservation biology and epidemiology. In particular, it considers models for resource
allocation and antimicrobial stewardship.
In a population model with a parabolic differential equation and density dependent
growth, we study the problem of allocating resources to maximize the net benefit
in the conservation of a single species while the cost of the resource allocation is
minimized. The net benefit is measured in terms of maximizing population abundance
and the goal of maximizing abundance is divided between the goal of maximizing the
overall abundance across space and time and the goal of maximizing abundance at
the final time. We consider cases that model a fixed amount of resource as well as
cases without this constraint. We regard the resource coefficient as a control and we
consider cases where this coefficient varies in space and time as well as cases where it
varies only in space. We establish the existence and uniqueness of the solution to the
state system given a control and the existence of an optimal control. We establish the
characterization of the optimal control and demonstrate uniqueness of the optimal
control. Numerical simulations illustrate several cases with Dirichlet and Neumann
boundary conditions.
We implement an agent-based model for Clostridium difficile transmission in
hospitals that accounts for several processes and individual factors including environmental and antibiotic heterogeneity in order to evaluate the efficacy of various control
measures aimed at reducing environmental contamination and mitigating the effects

v

of antibiotic use on transmission. In particular, we account for local contamination
levels that contribute to the probability of colonization and we account for both the
number and type of antibiotic treatments given to patients. Simulations illustrate
the relative efficacy of several strategies for the reduction of nosocomial colonizations
and nosocomial diseases.
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Chapter 1
Introduction
1.1

Optimal Control Theory

One of our goals in this work will be to determine the optimal growth coefficient for
a population model that satisfies a certain objective. The context for this problem
is the allocation of resources in conservation biology. Suppose that in an effort to
conserve some species, you have resources at your disposal to allocate in some time
horizon and across some habitat. What is the best way to do this? “Best” will
involve some tradeoff between the benefit to the species and the associated costs of
such allocation. This question has the two basic components of an optimal control
problem, a state system dependent on some control and an objective functional. In
this case the state system is a partial differential equation (PDE) that models the
dynamics of a population and is influenced by a control variable that models the
allocation of resources. Our objective functional models the goal of maximizing some
benefit to the population while minimizing the associated cost of resource allocation.
Optimal control theory evolved from the calculus of variations. In the 1950’s, L.S.
Pontryagin and his collaborators developed the Maximum Principle for the optimal
control of systems governed by ordinary differential equations (Pontryagin et al.,
1962). A simple case of this type of optimal control problem is as follows.
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Let control m belong to the set of admissible controls U . We seek m∗ ∈ U such
that
J(m∗ ) = max J(m)
m∈U

where
T

Z
J(m) =

f (t, x(t), m(t)) dt

(1.1.1)

0

subject to
d
x(t) = g (t, x(t), m(t))
dt

(1.1.2)

x(0) = x0
where (1.1.1) is the objective functional, (1.1.2) is the state equation and x is called
the state variable. If it exists, m∗ (t) is called an optimal control. We denote the
corresponding state, x∗ (t), and together they form an optimal pair.
The key idea of Pontryagin was to append the state equation to the objective
functional through the introduction of an adjoint variable. Using the adjoint function
and differentiating J with respect to control u at u∗ gives a characterization of the
optimal control in terms of the state and adjoint functions. The coupled state-adjoint
system together with the control characterization constitute the optimality system.
J.-L. Lions developed a general framework for analyzing optimal control problems
with state systems governed by partial differential equations (Lions, 1971, 1972).
While there is no full generalization of Pontryagin’s Maximum Principle to optimal
control of state systems governed by partial differential equations, some corresponding
“maximum principle” type results can be found in Li and Yong (1995).
The setting for the problem of optimal control of PDEs is similar. Let control m
belong to the set of admissible controls U . We seek m∗ ∈ U such that
J(m∗ ) = sup J(m),
m∈U

2

subject to
Lu(x, t) = g(x, t, u(x, t), m(x, t))
with appropriate initial and boundary conditions.

Here, L is a known partial

differential operator and u is the state variable. We outline the solution technique
employed in Chapter 2.
First, given a control, we establish the existence and uniqueness of the corresponding solution to the state system in an appropriate weak solution space. Then
the existence of an optimal control is established. A priori estimates of the states in
appropriate Sobolev spaces are needed for these results. Next, we derive necessary
conditions for an optimal pair giving rise to an optimality system consisting of the
coupled state-adjoint system and the characterization of the optimal control. Lastly,
proving the existence and uniqueness of the solution to the optimality system implies
the uniqueness of the optimal control.

1.2

Optimal Resource Allocation for a Parabolic
Population Model

The effects of spatial heterogeneity on the dynamics of a population is an important
issue in conservation biology. Motivated by the work of Cantrell and Cosner (Cantrell
and Cosner, 1989, 1991b,a), we consider a population whose dynamics are subject to
diffusion and density dependent, logistic growth. These dynamics are modeled by the
PDE on a bounded domain
u(x, t)t − µ∆u(x, t) = u(x, t) (m − u(x, t))
u(·, 0) = u0

(1.2.1)
(1.2.2)

with appropriate Neumann or Dirichlet boundary conditions and where u = u(x, t)
is the population density of a species at (x, t), µ > 0 is the diffusion coefficient, m
3

is a growth coefficient related to the intrinsic growth rate of the population and the
function u0 is given.
One source of spatial heterogeneity is the spatio-temporal allocation of resources.
Resource allocation can impact a population through its influence on the intrinsic
growth rate of the species. We regard m, therefore, a control variable and in Chapter 2
we consider four control problems that we briefly describe here.
Let Ω be an open, connected, bounded subset of Rn with C 1 boundary ∂Ω and
let Q = Ω × (0, T ) where T ∈ (0, ∞). Define the control set, U1 by
U1 = {m ∈ L∞ (Ω) : 0 ≤ m(x) ≤ M }.

(1.2.3)

where M reflects the upper bound for the rate of resource allocation.
Alternatively, we consider the case where there is a fixed amount of resource to
be allocated:
Z

∞

V1 = {m ∈ L (Ω) : 0 ≤ m(x) ≤ M,

m(x) dxdt = δ}.

(1.2.4)

Q

In each of these sets, the control is constant in time, m = m(x).
We seek m∗ ∈ U1 or m∗ ∈ V1 such that
J(m∗ ) = sup J(m)
m

where the objective functional, J1 , is defined by
Z
J1 (m) = A

Z
u(x, T ) dx +

Ω


u(x, t) − Bm(x)2 dxdt.

(1.2.5)

Q

and subject to (1.2.1) together with certain boundary and initial conditions. We
will emphasize Neumann boundary conditions but will also compare results to
problems with Dirichlet boundary conditions.
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Biologically, Neumann boundary

conditions represent a closed habitat whereas Dirichlet boundary conditions represent
an inhospitable boundary.
The objective functional models the goal of maximizing population abundance
while minimizing the quadratic costs associated with providing resources. The goal
of maximizing abundance is divided between the goal of maximizing the overall
abundance across space and time and the goal of maximizing abundance at the final
time (payoff goal). Here A measures the relative importance of the population level
at the final time, T , and B is a positive weight constant on the cost term.
We will also consider the case where m is a function of both space and time,
m = m(x, t). Define the control set U2 by
U2 = {m ∈ L∞ (Q) : 0 ≤ m(x, t) ≤ M }.

(1.2.6)

For the case of a fixed amount of resource, we have the control set
Z

∞

V2 = {m ∈ L (Q) : 0 ≤ m(x, t) ≤ M,

m(x, t) dxdt = δ}.

(1.2.7)

Q

We seek m∗ ∈ U2 or m∗ ∈ V2 such that
J2 (m∗ ) = sup J2 (m)
m

where the objective functional, J2 , is defined by
Z
J2 (m) = A

Z
u(x, T ) dx +

Ω


u(x, t) − Bm(x, t)2 dxdt,

(1.2.8)

Q

subject to (1.2.1) and where A measures the relative importance of the population at
time T compared with the population abundance over Q, and B is a positive weight
constant on the cost term.

5

1.3

Antimicrobial Stewardship for the Control of
Clostridium difficile Transmission in Healthcare Settings

Clostridium difficile is an important hospital-acquired enteric pathogen. In particular,
Clostridium difficile is the primary pathogen of antibiotic-associated colitis and
accounts for up to 20% of antibiotic associated diarrhea in hospitals (Bartlett, 2002).
The cost attributable to Clostridium difficile infection (CDI) in U.S. acute care
facilities is estimated to be as much as $4.8 billion per year (Dubberke and Olsen,
2012).
CDI prevention measures have not changed sufficiently to manage these rising
numbers. The focus of these measures is on testing symptomatic patients in order
to identify patients with CDI so that isolation and contact precautions can be taken
(Cohen et al., 2010; Dubberke et al., 2008). Recent studies, however, point out the
significance to transmission within the ward of both transmission pathways beyond
the ward itself and additional sources of CDI infections (Dubberke et al., 2014).
Successful control measures will come only with a better understanding of Clostridium
difficile transmission. In particular, there are three important sources of transmission
heterogeneity that contribute to the incidence of CDI and, as such, successful control
measures must take these into account.
One important source of transmission heterogeneity is environmental heterogeneity (Dubberke et al., 2008; Gerding et al., 2008). The risk of being colonized by
Clostridium difficile varies significantly with local contamination levels (Dubberke
et al., 2014). Control measures that address local contamination levels include contact
precautions as well as cleaning and disinfection of the environment (Gerding et al.,
2008).
Antibiotic treatments in hospitals provide another source of transmission heterogeneity. The CDI risk factors associated with antibiotics vary significantly by both
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number of treatments and type of antibiotic (Slimings and Riley, 2014; Dancer et al.,
2013). Antibiotic stewardship programs that reduce either the number of antibiotic
treatments or the relative proportion of high risk antibiotic treatments are, therefore,
important for the prevention and control of CDI (Feazel et al., 2014; Talpaert et al.,
2011).
Finally, the role of asymptomatic carriers is a significant source of transmission
heterogeneity. The admission of colonized, asymptomatic patients is significant to
sustaining nosocomial transmission Lanzas et al. (2011).

More effective control

measures require a better understanding of transmission and, therefore, require a
better understanding of the pre-admission history of patients with respect to factors
pertinent to CDI and how these factors contribute to within-ward transmission.
The goal of this study is to evaluate the efficacy of various control measures aimed
at reducing environmental contamination and mitigating the effects of antibiotic use
on transmission for reducing the nosocomial incidence of colonization and infection. In
Chapter 3 we, therefore, propose and implement an agent-based model for Clostridium
difficile transmission in hospitals that accounts for these environmental, antibiotic,
and patient heterogeneities.

7

Chapter 2
Optimal Resource Allocation for a
Parabolic Population Model
2.1

Background

Understanding the effects of spatial heterogeneity in a habitat on population dynamics
is an important issue in mathematical ecology (Kareiva et al., 1990; Tilman and
Kareiva, 1997; Lou, 2006; Cantrell et al., 2009). Partial differential equations (PDEs)
have long been used to model population dynamics (Murray, 2003; Holmes et al.,
1994) and reaction-diffusion equations, in particular, have been studied extensively
in spatial ecology (Okubo and Levin, 2001; Cantrell and Cosner, 2003). Skellam
(1951) proposed the PDE on a bounded domain
u(x, t)t − µ∆u(x, t) = u(x, t) (m(x) − u(x, t))

(2.1.1)

to describe the dynamics of a diffusing population that has density dependent,
logistic growth. Here, u(x, t) is the population density at (x, t), µ is the diffusion
rate and m(x) in the intrinsic growth rate of the population and can vary in
space. Given an initial function, u0 = u(·, 0), a solution to (2.1.1) will also satisfy
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appropriate boundary conditions such as no-flux (Neumann) or zero (Dirichlet)
boundary conditions.
Cantrell and Cosner (1989) showed that the persistence of a population whose
dynamics are modeled by (2.1.1), together with suitable boundary and initial
conditions, depends on a relationship between the diffusion coefficient µ and λ1 (m)
where λ1 (m) is the principal eigenvalue of the problem
−∆φ = λm(x)φ.
In another study (Cantrell and Cosner, 1991b), they extended those results for a
population model that included advection. In that case, persistence also depends
on the advection coefficient. Other studies that include advection and pertain to
persistence and are found in Belgacem and Cosner (1995); Cosner and Lou (2003);
Cantrell et al. (2008).
In (Cantrell and Cosner, 1991a), they considered the arrangement within a habitat
of “favorable” and “unfavorable” regions. Several such arrangements were considered
and judged according to how severe were the constraints on population persistence.
In particular, they considered steady states of (2.1.1) subject to Neumann, Dirichlet,
or Robin boundary conditions and where m = m(x) represents the intrinsic growth
rate of the population u and can be considered to represent the resource function. In
this work, Cantrell and Cosner considered the sign of m(x) to indicate whether the
habitat is favorable or unfavorable. To determine how suitable the overall habitat is
for persistence, and following Murray and Sperb (1983), they considered the size of
the principal eigenvalue of
−∆φ = λm(x)φ.
As the size of this eigenvalue increases, the maximum rate of diffusion that will allow
for persistence decreases.
Viewed from a slightly different perspective, one can think of the varying intrinsic
growth rate as a response to the allocation of resources. The problem is now cast as
9

how should resources be allocated in order to benefit the population. In addition to
its persistence, one may also consider the abundance of a population as in important
metric for the effectiveness of conservation effort. Ding et al. (2010) addressed this
question. In particular, they considered the following optimal control problem, using
the intrinsic growth rate m(x) as a control and the control set
Z

∞

U = {m ∈ L (Ω) | 0 ≤ m(x) ≤ M,

m(x) dx = δ},
Ω

where the integral constraint on m represents a fixed amount of resource to be
allocated. They showed the existence of an optimal control, m∗ ∈ U, such that
J(m∗ ) = max J(m)
m

where the objective functional is
Z h
i
J(m) =
u − (Bm2 ) dx,
Ω

subject to
−µ∆u = u(m − u)
∂u
= 0
∂ν

in

Ω

on ∂Ω.

Their objective functional sought to maximize the population level while minimizing
the quadratic cost of control.
Optimal control theory evolved from the calculus of variations. In the 1950’s, L.S.
Pontryagin and his collaborators developed the Maximum Principle for the optimal
control of systems governed by ordinary differential equations (Pontryagin et al.,
1962). The key idea of Pontryagin was to append the state equation to the objective
functional through the introduction of an adjoint variable. Using the adjoint function
and differentiating J with respect to control m at m∗ gives a characterization of the
optimal control in terms of the state and adjoint functions. The coupled state-adjoint
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system together with the control characterization constitute the optimality system.
J.-L. Lions developed a general framework for analyzing optimal control problems
with state systems governed by partial differential equations (Lions, 1971, 1972).
While there is no full generalization of Pontryagin’s Maximum Principle to optimal
control of state systems governed by partial differential equations, some corresponding
“maximum principle” type results can be found in Li and Yong (1995).
The studies just discussed concern steady state populations. There are, however,
ecologically relevant contexts where the species being managed is not at a steady
state. What spatio-temporal allocation of resources will maximize the population
abundance while taking into account the costs associated with allocation? We address
this question using the growth rate as a control in a parabolic PDE.

2.2

Problem Formulation

Let Ω be an open, connected, bounded subset of Rn with C 1 boundary ∂Ω and let
Q = Ω × (0, T ) where T ∈ (0, ∞). Let u = u(x, t) be the population density of a
species at (x, t) ∈ Q. We consider the problem:
ut − µ∆u = u(m − u)

in

Q

(2.2.1)

on Ω × {t = 0}.

u(·, 0) = u0

Here µ > 0 is the diffusion coefficient which is fixed. The function m = m(x) or
m = m(x, t), is the “resource” function which is assumed to be bounded. The initial
function u0 ∈ H 1 (Ω) ∩ L∞ (Ω) is given and non-negative. We will emphasize Neumann
boundary conditions
∂u
= 0 on ∂Ω × (0, T )
∂ν
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(2.2.2)

where ν is the outward normal vector on ∂Ω, but will also compare results with
Neumann boundary conditions to those with Dirichlet boundary conditions,
u = 0 on ∂Ω × (0, T ).

(2.2.3)

Biologically, Neumann boundary conditions represent a closed habitat for the species
under management. For comparison, we also consider Dirichlet boundary conditions
which means the population density is zero at the boundary due to a hostile area
outside the boundary.
The goal is to maximize population abundance while minimizing the costs
associated with providing resources. The goal of maximizing abundance is divided
between the goal of maximizing the overall abundance across space and time and
the goal of maximizing abundance at the final time (payoff goal). We formulate four
control problems. Suppose the resource function varies only in space; i.e. m = m(x).
Our control set is given by
U1 = {m ∈ L∞ (Ω) : 0 ≤ m(x) ≤ M }.

(2.2.4)

where M reflects the upper bound for the rate of resource allocation. Note that this
upper bound imposes a limit on the total amount of resource that can be allocated.
Alternatively, we consider the case where there is a fixed amount of resource to
be allocated across the entire space-time domain. This fixed amount is represented
by the integral of m over Q:
Z

∞

V1 = {m ∈ L (Ω) : 0 ≤ m(x) ≤ M,

m(x) dxdt = δ}.
Q

In this case, we note the necessary relationship imposed on M and δ:
Z
m(x) dxdt ≤ M T |Ω|.

δ=
Q

12

(2.2.5)

From a management perspective, if we require that all resources be allocated, then
we must be able to allocate a sufficient amount at any given point in Q.
We seek m∗ ∈ U1 or m∗ ∈ V1 such that
J1 (m∗ ) = sup J1 (m)
m

where the objective functional, J1 , is defined by
Z

Z


u(x, t) − Bm(x)2 dxdt

u(x, T ) dx +

J1 (m) = A
Ω

(2.2.6)

Q

and where A measures the relative importance of the population level at the final time,
T , and B is a positive weight constant on the cost term. The objective functional
models the goal described above to maximize population abundance (on Ω × T and
over Q) while minimizing the costs associated with providing resources.
We will also consider the case where m is a function of both space and time. Here
our control set U2 is given by
U2 = {m ∈ L∞ (Q) : 0 ≤ m(x, t) ≤ M }.

(2.2.7)

For the case of a fixed amount of resource, we have the control set
Z

∞

V2 = {m ∈ L (Q) : 0 ≤ m(x, t) ≤ M,

m(x, t) dxdt = δ}
Q

and the necessary relationship imposed on M and δ is the same as before.
We seek m∗ ∈ U2 or m∗ ∈ V2 such that
J2 (m∗ ) = sup J2 (m)
m

13

(2.2.8)

where the objective functional, J2 , is defined by
Z

Z

J2 (m) = A

u(x, T ) dx +
Ω


u(x, t) − Bm(x, t)2 dxdt,

(2.2.9)

Q

where A measures the relative importance of the population at time T compared with
the population abundance over Q, and B is a positive weight constant on the cost
term.
We consider our optimal control problems in appropriate weak solution spaces.

Weak Formulation for Neumann Boundary Conditions
The function u ∈ V = L2 ((0, T ), H 1 (Ω)) ∩ L∞ (Q) with ut ∈ V ∗ = L2 ((0, T ), H 1 (Ω)∗ )
and u(x, 0) = u0 (x) is said to be a weak solution of (2.2.1) with Neumann boundary
condition (2.2.2) if and only if
T

Z

Z
hut , φi dt +

0

Z
(µ∇u) · ∇φ dxdt =

Q

u(m − u)φ dxdt

(2.2.10)

Q

for all φ ∈ L2 ((0, T ), H 1 (Ω)), where the inner product h·, ·i is the duality between
H 1 (Ω)∗ and H 1 (Ω). For Dirichlet boundary condition (2.2.3), the solution space is
u ∈ L2 ((0, T ), H01 (Ω)) ∩ L∞ (Q) with ut ∈ L2 ((0, T ), H −1 (Ω)).

2.3

A priori Estimates and Existence of Solutions

In this section, we state some preliminary results needed for proving the existence of
and characterizing our optimal solutions. These results hold for both Dirichlet and
Neumann boundary conditions. The first lemma states that all solutions u of PDE
(2.2.1) must be positive.
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Lemma 2.3.1. Assume that m ∈ V2 and u0 ∈ L∞ (Ω) and u0 ≥ 0. Then, any weak
solution u of (2.2.1) with boundary condition (2.2.2) or (2.2.3) must be non-negative
on Q.
Proof. Consider the equation
ut − µ∆u = u(m − |u|).

(2.3.1)

Let v(x, t) = max{−u(x, t), 0}. Using the weak form of (2.3.1), we have
Z

Z

Z
∇u · ∇v dx =

ut v dx + µ
Ω

uv(m − |u|) dx, t ∈ [0, T ].

Ω

Ω

Consider the set (x, t) ∈ Q such that u(x, t) < 0. On this set we have
u = −v;

ut = −vt ;

∇u = −∇v;

v > 0.

Note that off this set, v = 0. Substitution yields
1d
2 dt

Z

Z

2

|∇v| dx =

v dx + µ
Ω

Z

2

Ω

v 2 (m − |u|) dx

ZΩ

v 2 m dx
ΩZ
≤M
v 2 dx.

≤

Ω

This implies
d
dt

Z

Z

2

v dx ≤ 2M
Ω

v 2 dx

Ω

and Gronwall’s inequality implies
Z

2

v dx ≤ e

2M T

Ω

Z
Ω
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v(x, 0)2 dx.

But u0 (x) = u(x, 0) ≥ 0 implies v(x, 0) = 0. Thus,

R
Ω

v 2 dx = 0, ∀t ∈ [0, T ] and we

have that v = 0 a.e. on Q, which gives u ≥ 0 a.e. on Q. This being the case, PDE
(2.3.1) is equivalent to PDE (2.2.1) and we have the result.
The next lemma will be used to show our objective functional J2 is bounded above.
Lemma 2.3.2. Under the above assumptions and for each m ∈ V2 , any weak solution
u of (2.2.1) with boundary condition (2.2.2) or (2.2.3) satisfies
Z
u(x, t)dx ≤ e

Mt

Z
u0 (x)dx, ∀ t ∈ [0, T ].

Ω

Ω

where M is the upper bound on m. In particular, there exists a positive constant C
such that
J2 (m) ≤ C||u0 ||L∞ (Ω) ,

for all m ∈ V2 .

Proof. Let t ∈ [0, T ]. Assume a weak solution exists and let the test function φ = 1.
Since u ≥ 0 by Lemma 2.3.1 and m ≤ M , we have um − u2 ≤ um ≤ uM and thus
Z

Z
u(m − u) dx ≤ M

ut dx =
Ω

Z

Ω

u dx.
Ω

Applying Gronwall’s inequality gives the first estimate and we have
Z

Z

J2 (m) = A

T

Z

u(x, T )dx +
Ω

Z

0

Z


u(x, t) − Bm(x, t)2 dxdt

Ω
T

Z

≤A

u(x, T )dx +
u(x, t) dxdt
0
Ω
Z
Z T
Z
MT
Mt
≤ Ae
u0 (x) dx +
e
u0 (x) dxdt
Ω
0
Ω

Z
Z T
MT
Mt
= Ae
+
e dt
u0 (x) dx
0
Ω

Z
eM T − 1
MT
= Ae
+
u0 (x) dx
M
Ω


eM T − 1
MT
≤ Ae
+
|Ω| · ||u0 ||L∞
M
Ω
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The rest of the section is devoted to prove the existence and a priori estimates of
the solutions u of the equation (2.2.1). Our first result is an energy estimate.
Lemma 2.3.3. For every m in V2 , there exists a constant C > 0 depending on µ, |Ω|
and T such that the following estimate holds for any weak solution u of (2.2.1) with
boundary conditions (2.2.2)
||u||L2 (0,T ;H 1 (Ω)) ≤ C||u0 ||L2 (Ω) .
Proof. It follows from Lemma 2.3.1 that u ≥ 0. Thus, using the weak formulation
with u as a test function, we get
1d
2 dt

Z

Z

2

2

(mu2 − u3 )dx
ΩZ
u2 dx
≤M

|∇u| dx =

u dx + µ
Ω

Z

Ω

(2.3.2)

Ω

where we used the upper bound on m and the non-negativity of u. This implies that
there is a constant C1 depending on the upper bound of our controls such that
d
dt

Z

2

Z

Z

u2 dx.

(2.3.3)

∀ 0 ≤ t < T.

(2.3.4)

|∇u(x, t)| dx ≤ C1

u(x, t) dx + µ
Ω

2

Ω

Ω

Gronwall’s inequality implies
Z

2

C1 T

Z

u0 (x)2 dx = eC1 T ||u0 ||2L2 (Ω)

u(x, t) dx ≤ e
Ω

Ω

Integrating (2.3.4) gives
Z
0

T

Z

u(x, t)2 dxdt ≤ T eC1 T ||u0 ||2L2 (Ω)

Ω
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(2.3.5)

Integrating inequality (2.3.3) over (0, T ) gives
Z

T

Z

d
dt

0

Z

T

Z

2

Z

0

Z

2

u(x, T ) dx −
Ω

Ω

Z

2

T

Z

0

Z

0

T

Z

u2 dxdt

0

1
|∇u(x, t)| dxdt ≤
µ
Ω

Z

2

Ω

Z

2

Ω
T

Z

|∇u(x, t)| dxdt ≤ C1

u(x, 0) dx + µ
Ω

Z

T

|∇u(x, t)| dxdt ≤ C1

u(x, t) dxdt + µ
Ω

Z

2

0

Z

2

T

Z

u(x, 0) dx + C1
0

Ω

u2 dxdt

Ω


u dxdt
2

Ω

This last estimate together with (2.3.5) yield

1
||u||2L2 (0,T ;H 1 (Ω)) ≤ T eC1 T ||u0 ||2L2 (Ω) +
||u0 ||2L2 (Ω) + C1 T eC1 T ||u0 ||2L2 (Ω)
µ


1 + C1 T eC1 T
C1 T
= Te
+
||u0 ||2L2 (Ω)
µ

Next we estimate the time derivative ut .
Lemma 2.3.4. For every m in V2 , there exists a constant C > 0 such that
the following estimate holds for any weak solution u of (2.2.1) with (2.2.2) and
||u||L∞ (Q) ≤ C1
||ut ||L2 (0,T ;H 1 (Ω)∗ ) ≤ C
with C depending on µ, |Ω|, ||u0 ||L∞ (Ω) , ||m||L∞ (Ω) , T and C1 .
Proof. For each φ ∈ L2 (0, T, H 1 (Ω)), the weak form of the solution u is
Z

T

Z
hut , φi dt = −µ

0

∇u · ∇φ dxdt
Z
Z
+
muφ dxdt −
u2 φ dxdt.
Q

Q

Q

Using the estimates for the states in L2 (0, T, H 1 (Ω)) we have
Z

T

hut , φi dt ≤ C||φ||L2 (0,T,H 1 (Ω))
0
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and thus
kut kL2 (0,T,H 1 (Ω)∗ ) ≤ C

(2.3.6)

with the constant C depending only on µ, |Ω|, T, ||u0 ||L∞ , ||m||L∞ and C1 .
Now we construct the weak solution of our state PDE by an iteration method.
Theorem 2.3.5. Let 0 < T < ∞ and u0 be non-negative, bounded in H 1 (Ω)∩L∞ (Ω).
Then, for each m ∈ V2 , there is a unique weak solution u of (2.2.1) with (2.2.2).
Moreover, there is a finite constant C > 0 depending only on |Ω|, µ, T, and ||u0 ||L∞
such that
0 ≤ u(x, t) ≤ C,

∀ (x, t) ∈ Q.

(2.3.7)

Proof. Consider the problem
Ut − µ∆U = mU
∂U
∂ν

= 0

U (x, ·) = u0 (x)

in

Q

on

∂Ω × (0, T )

on

Ω × {t = 0}.

(2.3.8)

The function U is a supersolution of (2.2.1) with (2.2.2) and by a maximum principle
for weak solutions of parabolic problems (Krylov, 1987) we have
0 ≤ U (x, t) ≤ ||u0 (x)||L∞ (Ω) eM T .
Let u1 = U and for i = 2, 3, ... let ui be the weak solution to
uit − µ∆ui + Rui = Rui−1 + ui−1 (m − ui−1 )

(2.3.9)

with initial condition u0 (x) and boundary condition (2.2.2) where
R > 2||u0 (x)||L∞ (Ω) eM T .
These solutions exist since these PDEs are linear in ui , given ui−1 (Evans, 2010).
Claim: For i = 1, 2, ... we have
0 ≤ ui ≤ U.
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Clearly, 0 ≤ u1 ≤ U . Now suppose 0 ≤ uj ≤ U for some j > 1. Then
uj+1
− µ∆uj+1 + Ruj+1 = Ruj + uj (m − uj )
t
= (R − (uj − m))uj
≥0
since uj − m ≤ uj ≤ U ≤ ||u0 (x)||L∞ (Ω) eM T ≤ R. Thus by the maximum principle
(Krylov, 1987), uj+1 ≥ 0. By induction we have 0 ≤ ui , for all i ∈ N. Furthermore,
since u1 = U , we have
u1t − µ∆u1 + Ru1 = Ru1 + mu1 .
Subtracting the uj+1 equation and using the induction hypothesis gives
(u1 − uj+1 )t − µ∆(u1 − uj+1 ) + R(u1 − uj+1 ) = R(u1 − uj ) + m(u1 − uj ) + (uj )2
≥ 0.
Now the maximum principle gives us u1 − uj+1 ≥ 0 which implies uj+1 ≤ U . By
induction we have ui ≤ U for all i ∈ N.
Next, we note that

∂
Rui−1 + ui−1 (m − ui−1 ) = R − (2ui−1 − m)
i−1
∂u
>0
since 2ui−1 − m ≤ 2U ≤ 2||u0 (x)||L∞ (Ω) eM T < R. That is, the right-hand side of PDE
(2.3.9) is increasing in ui−1 .
Claim: The state sequence is monotonically non-increasing:
ui+1 ≤ ui
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∀i ∈ N

Clearly u2 ≤ u1 = U . Suppose ui ≤ ui−1 . Then
(ui − ui+1 )t − µ∆(ui − ui+1 ) + R(ui − ui+1 )


= Rui−1 + ui−1 (m − ui−1 ) − Rui + ui (m − ui )
≥0
The result again follows by the maximum principle for weak solutions.
Note from the L∞ bound on U , we obtain
||ui ||L∞ (Q) ≤ C,
which is needed in the a priori estimates. By a similar argument as in Lemmas
(2.3.3) and (2.3.4), we obtain similar a priori estimates for ui . These estimates give
us weak convergences on a subsequence. We need, however, convergence on the whole
sequence due to the fact that PDE (2.3.9) involves ui and ui−1 . The monotonic
property established above gives us the weak convergences on the whole sequence.
That is, there exists u ∈ L2 (0, T, H 1 (Ω)) ∩ L∞ (Q) with ut ∈ L2 (0, T, H 1 (Ω)∗ ) such
that
ui * u ∈ V

(2.3.10)

uit * ut ∈ V ∗ .

(2.3.11)

Thus, in the weak form of (2.3.9) we have each of the terms on the left-hand side
converging. For the right-hand side, we have
Z
lim

i→∞

i−1

u

Z
mφ dxdt =

Q

umφ dxdt
Q
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since m ∈ L∞ (Q), φ ∈ L2 (Q) implies mφ ∈ L2 (Q). For the last term we have the
following
Z

Z


i 2

φ dxdt −

u
Q

Z

2

i

u (u − u)φ dxdt +

u φ dxdt =
Q

Z

i

Q

u(ui − u)φ dxdt

Q

Z

|ui − u||φ| dxdt

≤C
Q

Z
≤C

 12 Z
 21
2
|u − u| dxdt
|φ| dxdt .
i

2

Q

Q

Because of monotonicity and weak convergence, a result of Simon (1987) gives us
strong convergence,
ui → u ∈ L2 (Q),
and thus the right-hand side of the inequality goes to 0 as i → ∞ and we have
the desired convergence and that u satisfies PDE (2.2.10) with boundary condition
(2.2.2).
For uniqueness, suppose u and v both satisfy (2.2.10). Using u − v as a test
function in each PDE, subtracting and using a similar technique as in the proof of
Lemma (2.3.1) we have
d
dt

Z

Z

2

(u − v) dx ≤ C

(u − v)2 dx.

(2.3.12)

Ω

Ω

Gronwall’s inequality implies
Z

2

(u − v) dx ≤ e
Ω

CT

Z

(u0 (x) − v0 (x))2 dx ∀t ∈ [0, T ].

(2.3.13)

Ω

Thus u0 (x) = v0 (x) implies u = v.
Remark: Theorem (2.3.5) also holds for controls in U1 , V1 , and U2 . Moreover, the
results of this section are all valid for Dirichlet boundary conditions (2.2.3).
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2.4

Existence of an Optimal Control

To investigate the maximum of our objective functional, we first show the existence
of an optimal control.
Theorem 2.4.1. Assume that 0 < T < ∞, u0 ∈ L∞ (Ω) ∩ H 1 (Ω) and u0 is nonnegative. There exists an optimal control m∗ ∈ V2 maximizing the objective functional
J2 (m), with states satisfying PDE (2.2.1) and boundary condition (2.2.2).
Proof. By Lemma 2.3.2, J2 (m) ≤ C where C is a constant depending only on M ,
||u0 ||L∞ (Q) and T . Therefore, supm∈V2 J2 (m) exists. Let {mn } be a maximizing
sequence in V2 , i.e.
lim J2 (mn ) = sup J2 (m).

n→∞

(2.4.1)

m∈V2

Let un = u(mn ) be the corresponding state solution when the control is mn . We have
shown a priori estimates for the states in L2 ((0, T ), H 1 (Ω)) and in L∞ (Q) and their
time derivatives in L2 ((0, T ), H 1 (Ω)∗ ).
By passing to a subsequence and using that L2 (Q) is weakly compact, there exists
u∗ and m∗ such that
un * u∗ in L2 (0, T, H 1 (Ω)),

mn * m∗ in L2 (Q).
Since mn is also in V2 , we have
Z

mn dxdt = δ.

Q

Using the weak convergence in L2 (Q) and test function v = 1 we have
Z

Z

n

m dxdt →

δ=
Q

m∗ dxdt.

Q

That is, m∗ is in V2 . Note that (2.3.7) implies u∗ is in L∞ (Q).
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(2.4.2)

Using the estimate on the time derivative from Lemma 2.3.4, Brézis (2010) and
by passing to a subsequence, we have
un → u∗

in L2 (Q),

∇un * ∇u∗

in L2 (Q),

and
(2.4.3)

unt * u∗t in L2 ((0, T ), H 1 (Ω)∗ ).
We need to show that u∗ = u(m∗ ), meaning that u∗ is the state corresponding to m∗ ,
and that m∗ is an optimal control.
From these convergences, it follows
Z

Z

u∗t v dxdt,
Q
ZQ
Z
n 2
lim
(u ) φ dxdt = (u∗ )2 φ dxdt.
n→∞ Q
Q
Z
Z
n
lim
∇u · ∇v dxdt =
∇u∗ · ∇v dxdt.
lim

n→∞

n→∞

unt v

dxdt =

Q

(2.4.4)

Q

From the strong convergence of the sequence {un } and the weak convergence of the
sequence {mn }, we obtain
Z

Z

m∗ u∗ φ dxdt
m u φdxdt −
Q
Q
Z
Z
n
n
∗
(mn − m∗ ) φu∗ dxdt
m φ(u − u ) dxdt +
=
Q
Q
Z
n
∗
≤ M kφkL2 (Q) ku − u kL2 (Q) +
(mn − m∗ )φu∗ dxdt
n n

Q

→ 0,

as n → ∞.

using that φu∗ ∈ L2 (Q) due to u∗ ∈ L∞ (Q).
Collecting the four convergence limits above, we pass to the limit in the four terms
of our weak formulation of the PDEs for the un sequence and obtain u∗ = u(m∗ ).
Using the strong
convergence in L2 (Q) of the sequence un and the fact that the
Z
function m 7→
|m|2 dxdt is weakly lower semi-continuous in L2 (Q) (Brézis, 2010),
Q
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we obtain
n

Z

sup J(m) = lim J(m ) =
m∈U

n→∞

[u∗ − B|m∗ |2 ]dxdt = J(m∗ ).

Q

We conclude that m∗ ∈ U is an optimal control.
Remarks: A similar argument proves the case for control sets U1 , V1 , and U2 . The
results of this section are all valid for Dirichlet boundary conditions (2.2.3).

2.5

Derivation of the Optimality System

The optimality system consists of the coupled state-adjoint system together with the
characterization of the optimal control. We divide the characterizations into four
cases for U1 , V1 , U2 and V2 .

2.5.1

U1 = {m ∈ L∞ (Ω) : 0 ≤ m(x) ≤ M }

We consider first the case where m = m(x) and there is no specified amount of
resource to allocate. To obtain the necessary conditions, we need to differentiate
the map m 7→ J1 (m) with respect to the control m. We denote by u = u(m) the
unique, positive weak solution of PDE (2.2.1) with boundary condition (2.2.2). Since
u = u(m) appears in J1 (m), we first prove the appropriate differentiability of the map
m 7→ u(m) whose derivative is called the sensitivity.
Remark: Throughout this section we denote by ψ  the difference quotient
ψ =

u(m + l) − u(m)
.


Theorem 2.5.1 (Sensitivity). The mapping m ∈ U1 7→ u(m) ∈ V is differentiable
in the following sense: for each m, l in U1 such that m + l ∈ U1 for all  sufficiently
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small, then there exist ψ ∈ V and ψt ∈ V ∗ such that
ψ  * ψ weakly in V as  → 0,

(2.5.1)

(ψ  )t * (ψ)t weakly in V ∗ as  → 0,

(2.5.2)

and the sensitivity ψ satisfies
ψt − µ∆ψ − (m − 2u)ψ
∂ψ
∂ν
ψ

=

ul

in Q,

=

0

on ∂Ω × (0, T ),

=

0

on Ω × {t = 0}.

(2.5.3)

Proof. Let u = u (m ) where m = m+`. The state PDEs corresponding to controls
m and m are given by
ut − µ∆u = u (m − u )

(2.5.4)

ut − µ∆u = u (m − u) .

(2.5.5)

Taking differences and dividing by  we have:


u − u





− µ∆
t

u − u




u m − um (u )2 − u2
−



 
u −u
u − u 
(u + u) .
m + u ` −
=


=

(2.5.6)
(2.5.7)

The PDE satisfied by the difference quotient is given by
ψt − µ∆ψ  = (m − (u + u)) ψ  + u `

(2.5.8)

A priori estimates on the quotients ψ  can be shown similarly to the estimates on
the states:
||ψ  ||V ≤ C1

26

||ψt ||V ∗ ≤ C2 .
Thus there exists ψ ∈ V with ψt ∈ V ∗ that is the weak limit of ψ  as in (2.5.1)
and (2.5.2). Note that we also obtain u → u in V by ||u − u||V ≤ C1 . This
gives convergence of the u ` and u ψ  terms. By these convergences, the sensitivity ψ
satisfies the desired PDE. Similarly, the sensitivity PDE satisfies the given boundary
and initial conditions.
Next, we characterize our optimal control solution m∗ by differentiating the map
m 7→ J1 (m). We use the sensitivity equation to find our adjoint equation and our
characterization. The sensitivity PDE can be rewritten as Lψ = u` where

Lψ =


∂
− µ∆ − (m − 2u) ψ.
∂t

In order to introduce the sensitivity PDE into our objective functional, we make use
of an adjoint PDE. The formal adjoint of the operator L is the operator L∗ satisfying:
hp, Lψi = hL∗ p, ψi
in an L2 sense.

27

To see the specific terms, we integrate (formally) by parts:
Z

Z
p (ψt − µ∆ψ − (m − 2u)ψ) dxdt
(2.5.9)
Z
Z
Z
=
pψt dxdt − µ p∆ψ dxdt −
p(m − 2u)ψ dxdt
(2.5.10)
Q
Q
Q
Z
Z
Z
= − pt ψ dxdt + p(x, T )ψ(x, T ) dx − p(x, 0)ψ(x, 0) dx

pLψ dxdt =
Q

Q

Q

Ω

Ω

(2.5.11)
T
∂ψ
p
+ µ ∇p∇ψ dxdt − µ
dSdt
(2.5.12)
0
∂Ω ∂ν
Q
Z
−
p(m − 2u)ψ dxdt
(2.5.13)
Q
Z
Z
Z
= − pt ψdxdt + p(x, T )ψ(x, T )dx − p(x, 0)ψ(x, 0)dx (2.5.14)

Z

Z

Z

Q

Ω

Ω

Z

Z
−µ

T

Z
ψ

ψ∆p dxdt + µ
Q
Z T

0

Z

−µ
0

∂ψ
p
dSdt −
∂Ω ∂ν

∂Ω

∂p
dSdt
∂ν

(2.5.15)

Z
p(m − 2u)ψ dxdt.

(2.5.16)

Q

The boundary and initial conditions of the sensitivity PDE (2.5.3) give:
Z

Z

(−pt − µ∆p − p(m − 2u)) ψ dxdt

pLψ dxdt =
Q

(2.5.17)

Q

Z

Z

T

Z

∂p
p(x, T )ψ(x, T ) dx + µ
ψ
dSdt
∂ν
Ω
0
∂Ω
Z
Z
∗
=
ψL p dxdt + p(x, T )ψ(x, T ) dx
+

Q

(2.5.18)
(2.5.19)

Ω

Z

T

Z

+µ

ψ
0

∂Ω

∂p
dSdt.
∂ν

(2.5.20)

When we take the derivative (with respect to the control) of the terms in the integrand
of the objective functional that involve the state, we will have
∂ integrand of J1 ∂ state
·
=1·ψ
∂ state
∂ control
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This suggests how to define the right hand side (RHS) of the adjoint PDE. Namely,
the RHS of the adjoint PDE should be the derivative of the integrand with respect
to the state. The basic idea can be illustrated in this way:
∂ integrand of J1 ∂ state
·
= AdjointRHS · ψ = ψL∗ p = pLψ = p · StateRHS
∂ state
∂ control
Moreover, since J1 has a term involving the state at the final time (payoff term), a
similar line of reasoning suggests how to define the final time condition for the adjoint
PDE; i.e. p = A at t = T .
Theorem 2.5.2. Given an optimal control m∗ ∈ U1 and corresponding state u∗ =
u(m∗ ), there exists an adjoint p in L2 (0, T, H 1 (Ω)) ∩ L∞ (Q) which satisfies pt ∈
L2 ((0, T ), H 1 (Ω)∗ ) and
−pt − µ∆p − (m∗ − 2u∗ )p
∂p
∂ν
p

=

1

in Q,

= 0

on ∂Ω × (0, T ),

= A

on Ω × {t = T }.

(R T

))
(u∗ p)(x, t)dt
,0
2BT

(2.5.21)

Furthermore, m∗ is characterized by
(
m∗ (x) = min M, max

0

(2.5.22)

Proof. Suppose m∗ is an optimal control. Let l ∈ U1 such that m∗ + l ∈ U1 for
sufficiently small  > 0. Let u = u(m∗ + l) denote the unique solution of (2.2.1)
when the control term is m∗ + l.
Problem (2.5.21) is linear in p and its coefficients are measurable and bounded.
By the change of variable t → T −t, the existence and uniqueness of the weak solution
p of (2.5.21) follows by Galerkin’s method (Evans, 2010).
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Now, observe that the directional derivative of J1 with respect to the control at
m∗ in the direction of l satisfies
J1 (m∗ + l) − J1 (m∗ )
→0

Z
(u − u∗ )
= lim+ A
(x, T ) dx
→0

Ω

Z  
(u − u∗ )
(m∗ + l)(x)2 − m∗ (x)2
+ lim+
(x, t) − B
dxdt
→0


Q
Z
Z
= A ψ(x, T ) dx +
(ψ(x, t) − 2Bm∗ (x)l(x)) dxdt.

0 ≥ lim+

Ω

Q

Using the weak solution formulation for the adjoint problem with test function ψ, we
obtain
Z

Z

Z

T

Z

2Bm∗ (x)l(x) dxdt
ψ(x, t) dxdt −
0 ≥ A ψ(x, T ) dx +
0
Ω
Z Ω
ZQ
=
Aψ(x, T ) dx +
((−pt − (m∗ − 2u∗ )p)ψ + µ∇p · ∇ψ) dxdt
Ω
Q
Z
−T
2Bm∗ (x)l(x) dx
Ω
Z
Z
∗
∗
2Bm∗ (x)l(x) dx
((ψt − (m − 2u )ψ)p + µ∇p · ∇ψ) dxdt − T
=
Ω
ZQ
Z
=
pu∗ (x, t)l(x) dxdt − T
2Bm∗ (x)l(x) dx
Q

Z
=

(2.5.23)

Ω



Z T
∗
∗
(u p)(x, t) dt dx.
l(x) −2BT m (x) +

Ω

0

The sensitivity PDE was used to simplify this calculation.
Consider variation l with support on the set 0 < m∗ < M . Since m∗ is on the
interior of the control set, l can have arbitrary sign. Thus, on this set we have
∗

T

Z

(u∗ p)(x, t) dt = 0

−2BT m (x) +
0

which implies
RT
∗

m (x) =

0

u∗ p(x, t)dt
.
2BT
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On the set where m∗ = 0 and l has support, l ≥ 0 and we have
RT
m∗ (x) = 0 ≥

u∗ p(x, t)dt
.
2BT

0

Finally, on the set where m∗ = M and l has support, l ≤ 0 and we have
RT
∗

0

m (x) = M ≤

u∗ p(x, t)dt
.
2BT

Putting these cases together gives the desired control characterization.

2.5.2

V1 = {m ∈ L∞ (Ω) : 0 ≤ m(x) ≤ M,

R

Q m(x)

dxdt = δ}

To obtain a control characterization for the case with a fixed amount of resources, we
introduce a new state variable, w in H 1 (Ω) satisfying
∆w = m
in Ω
δ
∂w
=
on ∂Ω.
∂ν
T |∂Ω|

(2.5.24)

A weak solution to (2.5.24) exists (Evans, 2010). To see how this satisfies the desired
constraint, we integrate m over Ω, substitute the Laplacian of the new state and
integrate by parts:
Z

Z

m(x) dx

m(x) dxdt = T
Q

Ω

Z
=T

∆w dx
ZΩ
∇w · ν dSdx

=T
∂Ω

Z
=T
∂Ω

= δ.
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∂w
dSdx
∂ν

Remark: Consider the case n = 1 with Ω = (0, 1). Using the discrete measure,
|∂Ω| = 2, and we have
w00 (x) = m(x) in (0, 1)
w0 (0) · (−1) =

δ
2T

w0 (1) · (1) =

δ
2T

which gives the following:
Z

T

Z

1

Z

1

m(x) dxdt = T
0

0

m(x) dx
0

Z

1

w00 (x) dx
0

1
0
= T w (x)

=T

0

= T (w0 (1) − w0 (0))


δ
−δ
=T
−
2T
2T
= δ.
The problem of maximizing J1 (2.2.6) over V1 (2.2.5) is now recast as that of
maximizing J1 (2.2.6) over U1 (2.2.4) such that a corresponding pair (u, w) exists
satisfying (2.2.1) together with boundary condition (2.2.2) and (2.5.24) respectively.
Now we will have a system of two sensitivities, ψ1 and ψ2 .
Theorem 2.5.3 (Sensitivity). The mapping m ∈ U1 7→ (u, w)(m) is differentiable in
the following sense: for each m, l in U1 such that m + l ∈ U1 for all  sufficiently
small, then there exist ψ1 ∈ V, (ψ1 )t ∈ V ∗ and ψ2 ∈ H 1 (Ω), such that
ψ1 * ψ1 weakly in V as  → 0,

(2.5.25)

(ψ1 )t * (ψ1 )t weakly in V ∗ as  → 0,

(2.5.26)

ψ2 * ψ2 weakly in H 1 (Ω) as  → 0,
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(2.5.27)

and the sensitivities ψ1 and ψ2 satisfy
ψ1 t − µ∆ψ1 − (m − 2u)ψ1
∂ψ1
∂ν
ψ1

∆ψ2
∂ψ2
∂ν

=

=

ul

in Q,

=

0

on ∂Ω × (0, T ),

=

0

on Ω × {t = 0}.

l

(2.5.28)

in Ω,
(2.5.29)

= 0

on ∂Ω.

Proof. A priori estimates on the quotients ψ1 and ψ2 can be shown similarly to the
estimates on the states:
||ψ1 ||V ≤ C1
||(ψ1 )t ||V ∗ ≤ C2 .
||ψ2 ||V ≤ C3
Thus there exist ψ1 ∈ V with (ψ1 )t ∈ V ∗ and ψ2 ∈ H 1 (Ω) that are the weak limits of
ψ1 and ψ2 as in (2.5.25), (2.5.26), and (2.5.27).
That sensitivity ψ1 satisfies (2.5.28) was shown in Theorem 2.5.1. Let w = w (m )
where m = m + `. The state PDEs corresponding to controls m and m are given
by
∆w = m

(2.5.30)

∆w = m

(2.5.31)

Taking differences and dividing by  we have:

∆

w − w
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=`

(2.5.32)

That is, the PDE satisfied by the difference quotient is given by
∆ψ2 = `

(2.5.33)

Note that ψ2 doesn’t depend on epsilon and the sensitivity ψ2 satisfies the desired
PDE. Similarly, the sensitivity satisfies the given boundary conditions.
Theorem 2.5.4. Given an optimal control m∗ in V1 and corresponding state (u∗ , w∗ ),
there exists (p1 , p2 ) with p1 ∈ L2 (0, T, H 1 (Ω)) ∩ L∞ (Q), p1t ∈ L2 ((0, T ), H 1 (Ω)∗ ), and
p2 ∈ H 1 (Ω) satisfying
−p1t − µ∆p1 − (m∗ − 2u∗ )p1
∂p1
∂ν
p1
∆p2
∂p2
∂ν

=

1

in Q,

= 0

on ∂Ω × (0, T ),

= A

on Ω × {t = T }.

=

0

(2.5.34)

in Ω,
(2.5.35)

= 0

on ∂Ω.

Furthermore, m∗ is characterized by
(
m∗ (x) = min M, max

(

p2 (x) +

))
∗
(u
p
)(x,
t)dt
1
0
,0
2BT

RT
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(2.5.36)

Proof. The proof follows just as with Theorem 2.5.2 except that inequality (2.5.23)
picks up an extra term for the new state:
Z
0≥A

Z
ψ1 dxdt − T

ψ1 (x, T ) dx +
ZΩ

=A

Z

ZQ

2Bm∗ l dx

Ω

ψ1 (x, T ) dx +
((− (p1 )t − (m∗ − 2u∗ )p1 )ψ1 + µ∇p1 · ∇ψ1 ) dxdt
Ω
Q
Z
Z
∗
2Bm l dx − ∇p2 · ∇ψ2 dx
−T
Ω

Ω

Z

(((ψ1 )t − (m∗ − 2u∗ )ψ1 )p1 + µ∇p1 · ∇ψ1 ) dxdt
Q
Z
Z
∗
−T
2Bm l dx + p2 l dx
Ω
ZΩ
Z
l(x)(u∗ p1 )(x, t) dxdt − l(x) (2BT m∗ (x) − p2 (x)) dx
=

=

Ω

Q

Z
=



Z T
∗
∗
l(x) −2BT m (x) + p2 (x) +
(u p1 )(x, t) dt dx.

Ω

0

(2.5.37)
Again, by taking cases on the sets where 0 < m∗ < M , m∗ = M , and m∗ = 0, one
obtains the desired control characterization.
Remark: The solution p2 to (2.5.35) is a constant chosen in such a way that the
integral constraint on m is satisfied.

2.5.3

U2 = {m ∈ L∞ (Q) : 0 ≤ m(x, t) ≤ M }

We now consider our control as a function of both space and time. In order to
characterize the optimal control, we need to differentiate the maps m 7→ J2 (m) and
m 7→ u(m) with respect to the control m.
Theorem 2.5.5 (Sensitivity). The mapping m ∈ U2 7→ u(m) ∈ V is differentiable
in the following sense: for each m, l in U2 such that m + l ∈ U2 for all  sufficiently
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small, then there exist ψ ∈ V and ψt ∈ V ∗ such that
ψ  * ψ weakly in V as  → 0,

(2.5.38)

(ψ  )t * (ψ)t weakly in V ∗ as  → 0,

(2.5.39)

and the sensitivity ψ satisfies
ψt − µ∆ψ − (m − 2u)ψ
∂ψ
∂ν
ψ

=

ul

in Q,

=

0

on ∂Ω × (0, T ),

=

0

on Ω × {t = 0}.

(2.5.40)

Proof. The proof is similar to the proof of Theorem 2.5.1.
Next we use the adjoint function for our control characterization.
Theorem 2.5.6. Given an optimal control m∗ ∈ U2 and corresponding state u∗ =
u(m∗ ), there exists an adjoint p in L2 (0, T, H 1 (Ω)) ∩ L∞ (Q) which satisfies pt ∈
L2 ((0, T ), H 1 (Ω)∗ ) and
−pt − µ∆p − (m∗ − 2u∗ )p
∂p
∂ν
p

=

1

in Q,

= 0

on ∂Ω × (0, T ),

= A

on Ω × {t = T }.

(2.5.41)

Furthermore, m∗ is characterized by
∗





m (x, t) = min M, max
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(u∗ p)(x, t)
,0
2B

(2.5.42)

Proof. The directional derivative of J2 with respect to the control at m∗ in the
direction of l satisfies
J2 (m∗ + l) − J2 (m∗ )
→0
 Z  

Z 
Z
u (x, T ) − u∗ (x, T )
u − u∗
(m∗ + l)2 − m∗2
= lim+ A
dx +
dxdt − B
dxdt
→0



Ω
Q
Q
Z
Z
Z
= A ψ(x, T ) dx +
ψ dxdt −
2Bm∗ l dxdt.

0 ≥ lim+

Ω

Q

Q

Using the weak solution formulation for the adjoint problem with test function ψ, we
obtain
Z
0≥A

Z
ψ dxdt −

ψ(x, T ) dx +
Ω

Z

Z

Q

2Bm∗ l dxdt

Q

Z

ψ(x, T ) dx +
((−pt − (m∗ − 2u∗ )p)ψ + µ∇p · ∇ψ) dxdt
Ω
Q
Z
2Bm∗ l dxdt
−
Q
Z
Z
∗
∗
2Bm∗ l dxdt
((ψt − (m − 2u )ψ)p + µ∇p · ∇ψ) dxdt −
=
Q
ZQ
=
u∗ lp − 2Bm∗ l dxdt
ZQ
=
l (u∗ p − 2Bm∗ ) dxdt.

=A

(2.5.43)

Q

Taking cases on the sets where 0 < m∗ < M , m∗ = M , and m∗ = 0, one obtains
the desired control characterization.

2.5.4

V2 = {m ∈ L∞ (Q) : 0 ≤ m(x, t) ≤ M,

R

Q m dxdt

= δ}

To obtain a control characterization for the case with a fixed amount of resources, we
once again introduce a new state variable, w in H 1 (Ω) satisfying
RT
∆w = 0 m(x, t) dt
∂w
δ
=
∂ν
|∂Ω|
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in

Ω

on ∂Ω.

(2.5.44)

To see how this satisfies the desired constraint, we integrate m over Q, substitute the
new state and integrate by parts:
T

Z Z
Ω


Z
m(x, t) dt dx =
∆w(x) dx
Ω
Z
=
∇w · ν dSdx
Z∂Ω
∂w
dSdx
=
∂Ω ∂ν

0

=δ
Remark: Consider the case n = 1 with Ω = (0, 1). Using the discrete measure,
|∂Ω| = 2, and we have
w00 (x) =

RT
0

w0 (0) · (−1) =

δ
2

w0 (1) · (1) =

δ
2

m(x, t) dt in (0, 1)

which gives the following:
Z
0

1

Z
0

T


Z 1
w00 (x) dx
m(x) dt dx =
0


1
0
= w (x)
0

= (w0 (1) − w0 (0))


δ −δ
=
−
2
2
= δ.
The problem of maximizing J2 (2.2.9) over V2 (2.2.8) is now recast as that of
maximizing J2 (2.2.9) over U2 (2.2.7) such that a corresponding pair u, w exists
satisfying (2.2.1) together with boundary condition (2.2.2) and (2.5.44) respectively.
Now we will have a system of two sensitivities, ψ1 and ψ2 .
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Theorem 2.5.7 (Sensitivity). The mapping m ∈ U2 7→ (u, w)(m) is differentiable in
the following sense: for each m, l in U2 such that m + l ∈ U2 for all  sufficiently
small, then there exist ψ1 ∈ V, (ψ1 )t ∈ V ∗ and ψ2 ∈ H 1 (Ω), such that
ψ1 * ψ1 weakly in V as  → 0,

(2.5.45)

(ψ1 )t * (ψ1 )t weakly in V ∗ as  → 0,

(2.5.46)

ψ2 * ψ2 weakly in H 1 (Ω) as  → 0,

(2.5.47)

and the sensitivities ψ1 and ψ2 satisfy
ψ1 t − µ∆ψ1 − (m − 2u)ψ1
∂ψ1
∂ν
ψ1

∆ψ2
∂ψ2
∂ν

=

=

ul

in Q,

=

0

on ∂Ω × (0, T ),

=

0

on Ω × {t = 0}.

RT

l dt

in Ω,

0

on ∂Ω.

0

=

(2.5.48)

(2.5.49)

Proof. A priori estimates on the quotients can be shown similarly to the estimates
on the states. That sensitivity ψ1 satisfies 2.5.48 is shown similar to that in Theorem
(2.5.5). Let w = w (m ) where m = m + `. The state PDEs corresponding to
controls m and m are given by


Z

T

∆w =

m dt

(2.5.50)

m dt

(2.5.51)

0

Z
∆w =

T

0

Taking differences and dividing by  we have:

∆

w − w
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Z
=

T

` dt
0

(2.5.52)

That is, the PDE satisfied by the difference quotient is given by
∆ψ2

Z

T

` dt

=

(2.5.53)

0

Note that ψ2 doesn’t depend on epsilon and the sensitivity ψ2 satisfies the desired
PDE. Similarly, the sensitivity functions satisfy the given boundary conditions.
Theorem 2.5.8. Given an optimal control m∗ and corresponding state (u∗ , w∗ ), there
exists (p1 , p2 ) with p1 ∈ L2 (0, T, H 1 (Ω)) ∩ L∞ (Q), (p1 )t ∈ L2 ((0, T ), H 1 (Ω)∗ ), and
p2 ∈ H 1 (Ω) satisfying
− (p1 )t − µ∆p1 − (m∗ − 2u∗ )p1
∂p1
∂ν
p1
∆p2
∂p2
∂ν

=

=

1

in Q,

= 0

on ∂Ω × (0, T ),

= A

on Ω × {t = T }.

0

(2.5.54)

in Ω,
(2.5.55)

= 0

on ∂Ω.

Furthermore, m∗ is characterized by
∗



m (x, t) = min M, max




p2 (x) + (u∗ p1 )(x, t)
,0
2B

40

(2.5.56)

Proof. The proof follows just as with Theorem 2.5.6 except (2.5.43) picks up an extra
term for the new state:
Z

Z

∗

Z

0 ≥ A ψ1 (x, T ) dx + (1 · ψ1 − 2Bm l) dxdt + 0 · ψ2 dx
Q
Ω
Z Ω
=
p1 (x, T )ψ1 (x, T ) dx
Ω Z
((− (p1 )t − (m∗ − 2u∗ )p1 )ψ1 + µ∇p1 · ∇ψ1 − 2Bm∗ l) dxdt
+
ZQ
− ∇p2 · ∇ψ2 dx
Ω
Z
=
(((ψ1 )t − (m∗ − 2u∗ )ψ1 )p1 + µ∇p1 · ∇ψ1 − 2Bm∗ l) dxdt

(2.5.57)

Q

Z
+

Z

T

p2 (x)

l(x, t) dt dx
Z
Z
∗
∗
u lp1 − 2Bm l dxdt +
p2 (x)l(x, t) dxdt
=
Q
Q
Z


=
l(x, t) (u∗ p1 )(x, t) − 2Bm∗ (x, t) + p2 (x) dxdt.
Ω

0

Ω

Again, by taking cases on the sets where 0 < m∗ < M , m∗ = M , and m∗ = 0, one
obtains the desired control characterization.
Remarks: The solution p2 to (2.5.55) is a constant chosen in such a way that the
integral constraint on m is satisfied. The results of this section are all valid for
Dirichlet boundary conditions (2.2.3).

2.6

Uniqueness of Optimal Control

The coupled state and adjoint equations with initial and boundary conditions together
with the control characterization form the optimality system. In this section, we show
the uniqueness of solutions for each of the optimality systems in section 2.5 under
condition of small T , which gives the uniqueness of the optimal control. Such a
condition on T is common in optimal control with time-varying dynamics (Neilan
and Lenhart, 2011; Fister, 1997, 2001; Lenhart et al., 1999).
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Theorem 2.6.1. There exists a positive number T0 such that if 0 < T ≤ T0 , then there
is a unique optimal control for the problem with control set U2 (2.2.7) and objective
functional J2 (2.2.9).
Proof. From the result in Section 2.4, there exists an optimal control, and corresponding adjoints and states satisfying the optimality system. Thus, it suffices to prove the
uniqueness of the solutions of the optimality system as that will imply the uniqueness
of the optimal control.
For i = 1, 2, let ui , pi , mi be the states, adjoints, and controls solving the optimality
system. Let ui = eλt wi and pi = e−λt πi for λ a positive constant to be chosen below.
Substitution into the optimality system gives
λwi + (wi )t − µ∆wi = wi (m∗i − eλt wi ),
λπi − (πi )t − µ∆πi = πi (m∗i − 2eλt wi ) + 1
and
m∗i

n
n w π oo
i i
= min M, max
,0 .
2B

Subtracting we get
λ(w1 − w2 ) + (w1 − w2 )t = µ∆(w1 − w2 ) + m∗1 (w1 − w2 ) + w2 (m∗1 − m∗2 )
−eλt (w1 + w2 )(w1 − w2 )
and
λ(π1 − π2 ) − (π1 − π2 )t = µ∆(π1 − π2 ) + m∗1 (π1 − π2 ) + π2 (m∗1 − m∗2 )
−2eλt (π1 (w1 − w2 ) + w2 (π1 − π2 )) .
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Using (w1 − w2 ) and (π1 − π2 ) in the weak formulations respectively, we obtain
Z

1
(w1 − w2 )2 (x, T ) dx + λ
2

Ω

Z
=

Z

Z

2

|∇(w1 − w2 )|2 dxdt

(w1 − w2 ) dxdt + µ
Q

Q

(m∗1 − eλt (w1 + w2 ))(w1 − w2 )2 + w2 (m∗1 − m∗2 )(w1 − w2 ) dxdt

Q

and
Z
Ω

1
(π1 − π2 )2 (x, 0) dx + λ
2
Z

Z

Z

2

(π1 − π2 ) dxdt + µ
Q

|∇(π1 − π2 )|2 dxdt

Q

(m∗1 − 2eλt w2 )(π1 − π2 )2 + π2 (m∗1 − m∗2 )(π1 − π2 )

=
Q

−2eλt π1 (w1 − w2 )(π1 − π2 ) dxdt .
Now, we estimate (m∗1 − m∗2 ):
|m∗1 − m∗2 | ≤
=
=
=
=

1
|u1 p1 − u2 p2 |
2B
1
|w1 π1 − w2 π2 |
2B
1
|w1 π1 − w1 π2 + w1 π2 − w2 π2 |
2B
1
|w1 (π1 − π2 ) + π2 (w1 − w2 )|
2B
1
|π1 (w1 − w2 ) + w2 (π1 − π2 )|
2B

The spatial gradient terms from the left hand sides and the eλt (w1 + w2 )(w1 − w2 )2
and 2eλt w2 (π1 − π2 )2 terms from the right hand sides can be eliminated from the
inequality estimates due to their signs. Using the estimate on |m∗1 − m∗2 | and the
upper bound on m∗1 , we have
Z
Ω

1
(w1 − w2 )2 (x, T ) dx + λ
2
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Z
Q

(w1 − w2 )2 dxdt

|w2 |
(|π2 |(w1 − w2 )2 + |w1 (π1 − π2 )(w1 − w2 )|) dxdt
2B
Q

Z 
|w2 ||π2 |
|w1 ||w2 |
≤
M+
(w1 − w2 )2 +
|(π1 − π2 )(w1 − w2 )| dxdt
2B
2B
Q
Z

≤

M (w1 − w2 )2 +

and
Z
Ω

≤

Z 
Q

1
(π1 − π2 )2 (x, 0) dx + λ
2

Z

(π1 − π2 )2 dxdt

Q

|π2 |
(|w2 |(π1 − π2 )2 + |π1 (w1 − w2 )(π1 − π2 )|)
2B

−2eλt |π1 ||(w1 − w2 )(π1 − π2 )| dxdt

M (π1 − π2 )2 +

Summing these two inequalities and continuing to estimate we have
Z
Ω

Z

1
2
(w1 − w2 ) (x, T ) dx + λ
(w1 − w2 )2 + (π1 − π2 )2 dxdt
2
Q
Z
1
(π1 − π2 )2 (x, 0) dx
+
2
Ω
Z

|w2 ||π2 |
≤ (M +
) (w1 − w2 )2 + (π1 − π2 )2 dxdt
2B
Q
Z
|w1 ||w2 | + |π1 ||π2 |
− 2eλT |π1 |) |(w1 − w2 )(π1 − π2 )| dxdt
+ (
2B
Q

By Cauchy’s inequality and the L∞ bounds on πi and wi we have
Z
Ω

1
(w1 − w2 )2 (x, T ) dx +
2

Z



λ − C1 + C2 eλT
(w1 − w2 )2 + (π1 − π2 )2 dxdt
Q
Z
1
(π1 − π2 )2 (x, 0) dx ≤ 0
+
Ω 2

Let λ > C1 + C2 . Then for T small enough, we get λ > C1 + C2 eλT and, thus,
(w1 − w2 ) = (π1 − π2 ) = 0. That is, the solution to the optimality system is unique
which gives the uniqueness of the optimal control.
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2.7

Numerical Results

Using numerical simulations, we illustrate various scenarios on a one dimensional
spatial domain. Let Ω = (0, 1) and diffusion coefficient µ = 0.1. Our state equation
is given by
ut − 0.1uxx = u(m − u) in (0, 1) × (0, T ).
We will consider cases with m = m(x, t) and m = m(x). We emphasize Neumann
boundary conditions, ux (0, t) = ux (1, t) = 0, but, in the first three scenarios,
we will compare the case with Neumann boundary conditions to the case with
Dirichlet boundary conditions. Our baseline initial condition represents a population
concentrated in the center of the spatial domain and is shown in Figure 2.1. In two
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Figure 2.1: Baseline initial condition with single peak centered in the domain
scenarios we will consider different initial conditions. The baseline value for the upper
bound on the control is M = 1. The baseline value for the final time is T = 1 but in
two scenarios we will use T = 0.2. We also compare cases with and without a payoff
term and with and without an integral constraint on m. Finally, for all but the last
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Table 2.1: Baseline values for simulations.
Variable Description
Baseline
µ
diffusion coefficient
0.1
M
upper bound on control m
1
BCs
boundary conditions
Neumann
ICs
initial conditions
Fig. 2.1
T
final time
1
A
weight coefficient on payoff term
0
B
weight coefficient on the cost term
0.05

Alternates

Dirichlet
Figs. 2.3, 2.5
0.2
0.5
0.2

scenario we consider, the value for the weight coefficient on the cost term is B = 0.05.
These values are summarized in Table 2.1. For all scenarios, each of these baseline
values hold unless stated otherwise.
Since we have an initial state condition and a final time adjoint condition, a
forward-backward sweep iterative method is used to solve the optimality system
(Hackbusch, 1978; Lenhart and Workman, 2007). If there is no integral constraint
on the control variable m, after initializing our control, the state equation is solved
forward in time and then the adjoint equation is solved backward in time. We then
use the control characterization to update the control. If m = m(x), the control
characterization is given by equation (2.5.22),
(

(R T

m∗ (x) = min M, max

0

))
(u∗ p)(x, t)dt
,0
.
2BT

If m = m(x, t), the control characterization is given by equation (2.5.42),

 ∗

(u p)(x, t)
m (x, t) = min M, max
,0
.
2B
∗

This process is repeated until controls from successive iterates are sufficiently close.
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In the cases with an integral constraint on the control, the control characterization
is given by equation (2.5.36),
(

(

∗

m (x) = min M, max

p2 +

RT
0

))
(u∗ p1 )(x, t)dt
,0
,
2BT

if m = m(x) or by equation (2.5.56),



p2 (x) + (u∗ p1 )(x, t)
,0
,
m (x, t) = min M, max
2B
∗

if m = m(x, t). In these cases, we first make an initial guess for the solution to
the adjoint function, p2 . Recall that this is some constant chosen so that the integral
R
constraint, Q m dxdt = δ, is satisfied. Then the forward-backward sweep is performed
as described above. We then estimate the integral of our control using a trapezoid
method. The size of this integral indicates how we are to update our guess for the
adjoint p2 . We repeat the entire process until the difference between the integral and
δ is sufficiently small.
Finite differences are used to approximate derivatives. We use a forward difference
approximation for the time derivative:
ut (x, t) ≈

u(x, t + ∆t) − u(x, t)
.
∆t

A centered difference approximation is used for the second space derivative:
uxx (x, t) ≈

u(x − ∆x, t) − 2u(x, t) + u(x + ∆x, t)
.
(∆x)2

For these simulations, we let ∆x = 0.01. Choosing ∆t =

(∆x)2
,
4

we require µ ≤ 2 to

satisfy the CFL stability criterion for this method (LeVeque, 2007).
We begin by contrasting Neumann and Dirichlet boundary conditions for the
case m = m(x, t).

We can see in Figure 2.2 that more control is applied for
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Neumann boundary conditions than for the case with Dirichlet boundary conditions.
R
In particular, Q m(x, t)dxdt = 0.8144 for Neumann boundary conditions, whereas
R
m(x, t)dxdt = 0.4885 for the case with Dirichlet boundary conditions. It makes
Q
sense to invest more on allocating resources for a population not subject to an
inhospitable boundary. A larger value for the objective functional is also achieved for
the case with Neumann boundary conditions, 0.2056 compared to 0.1286.

Figure 2.2: Optimal control and corresponding states for Neumann (on left) and
Dirichlet (on right) boundary conditions with initial condition shown in Figure 2.1
Next we consider an initial population distribution with two peaks of the same
size: one in the middle of the domain and another to one side of the domain, as shown
in Figure 2.3. We again contrast the case with Neumann boundary conditions to that
with Dirichlet boundary conditions. The final time has been changed to T = 0.2. The
results are shown in Figure 2.4. In the case of Neumann boundary conditions, there is
no distinction between the control levels applied to the two population concentrations.
This is not the case, however, when we consider Dirichlet boundary conditions. In the
figure it is clear that more control is applied to the population in the center. From an
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ecological perspective, it makes sense to invest more in the population that is further
away from the inhospitable boundary. The values for the objective functional at the
optimal control for the two cases are 0.0396 for Neumann boundary conditions and
0.0333 for Dirichlet boundary conditions.
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Figure 2.3: Initial condition with centered peak and peak near boundary
Next we examine how resources are optimally allocated for a population that
is concentrated near an inhospitable boundary. Consider the initial condition in
Figure 2.5) with Dirichlet boundary conditions and final time T = 1. In Figure 2.6,
one can see how an optimal control will “drive” the population toward the center of
the domain and away from the hostile boundary.
For the remaining cases we only consider Neumann boundary conditions and the
baseline initial condition shown in Figure 2.1. Figure 2.7 compares the cases with
m = m(x, t) and varying values for the final time, T = 1 and T = 0.2 respectively.
We see that in the case with more time, more control is applied early in the time
domain compared to the same interval of time for the other case. Ecologically, it is
worthwhile to invest more in resources if there is more time to allocate them. The
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Figure 2.4: Optimal control and corresponding states for Neumann (on left) and
Dirichlet (on right) boundary conditions with initial condition shown in Figure 2.3,
T = 0.2
values for the objective functional at the optimal control for the two cases are 0.2056
for T = 1 and 0.0331 for T = 0.2.
The remaining cases all have final time T = 1. Comparing the case where the
control is a function of both time and space to the case where the control is constant
in time illustrates that, with the ability to vary the control in time, one can achieve
a larger value for the objective functional. In Figure 2.8, the value of the objective
functional for the space and time varying case is J = 0.2056 while the value of the
objective functional for the constant in time case is J = 0.2000.
We now compare cases with and without an integral constraint on the control.
An integral constraint will have an impact on the form of the optimal control. In
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Figure 2.5: Initial condition with single peak near boundary
Figure 2.9 we compare these two cases for m = m(x, t). In this case the constraint is
given by
Z
m(x, t) dxdt = 0.3.
Q

We see that under the integral constraint, the control is applied early; the control
equals zero beyond t = 0.6. With a fixed amount to invest, it is optimal to invest
it all early. Furthermore, less control is applied where the population concentrations
are small than in the case with no integral constraint. For comparison, we note
that the total integral of m over Q for the case without the integral constraint is
R
m(x, t) dxdt = 0.8. The values for the objective functional for the cases with and
Q
without the integral constraint are J = 0.2056 and J = 0.1861 respectively. If, in
addition to an integral constraint, we restrict the control such that m = m(x), the
value of the objective functional is J = 0.1739 (see left side of Figure 2.10). One can
see how the value of the objective functional at the optimal control decreases when
there is an integral constraint and decreases further when the control can only vary
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Figure 2.6: Optimal control and corresponding state for Dirichlet boundary
conditions with initial condition shown in Figure 2.5, T = 1
in space, which is expected since these two optimal controls are admissible controls in
U2 . Figure 2.10 shows the two cases m = m(x, t) and m = m(x) with each having an
integral constraint on m. As noted above, it is optimal to invest the allotted control
amount early. When the control is restricted to varying in space only, this is no longer
possible. While the amount of resource allocated for both of these cases is the same,
R
the overall population abundance, Q u(x, t) dxdt, is 0.1975 for m = m(x, t) compared
to 0.1810 for m = m(x).
Figure 2.11 illustrates the cases with and without an integral constraint on the
control but with m = m(x) in both cases. In this case the constraint is given by
Z
m(x) dxdt = 0.3.
Q

The values for the objective functional for the cases with and without the integral
constraint are J = 0.2000 and J = 0.1739 respectively. The total integral of m over
R
Q for the case without the integral constraint is Q m(x) dxdt = 0.9737.
Finally, we consider cases involving a final time payoff term in the objective
functional. The weight coefficient on this term in the objective functional is A = 0.5.
R
For the case where m = m(x, t), the final time population size, Ω u(x, T ) dx, is
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Figure 2.7: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and varying final time T = 1
(on left) and T = 0.2 (on right)
0.2946 when there is no final time payoff term compared to 0.3494 when there is a
final time payoff term. This is illustrated in Figure 2.12. One can see the effect of
the payoff term on the states. The state surface at the final time for the case with
the payoff term (on the right) is higher than the state surface at the final time for the
case without the payoff term (on the left). The effect on the corresponding controls
is also evident. The presence of the payoff term in the objective functional in this
case results in the application of maximum control for nearly the entire space-time
domain. The values for the objective functional at the optimal control for these two
cases are 0.2056 for A = 0 and 0.3747 for A = 0.5.
These observations hold also for the case where m = m(x). The final time
R
population size, Ω u(x, T ) dx is 0.3431 when there is no payoff term, compared to
0.3495 when there is a payoff term. This is illustrated in Figure 2.13. The state
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Figure 2.8: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and with controls m = m(x, t)
(on left) and m = m(x) (on right)
surface at the final time for the case with the payoff term (on the right) is higher
than the state surface at the final time for the case without the payoff term (on the
left). The presence of the payoff term in the objective functional in this case results
in the application of maximum control over the entire space-time domain. The values
for the objective functional at the optimal control for these two cases are 0.2000 for
A = 0 and 0.3746 for A = 0.5.
Recall that the weight coefficient on the quadratic cost has been B = 0.05 for
all of the cases illustrated thus far. If we choose a higher weight coefficient on the
quadratic cost, the result is different. Figure 2.14 illustrates the case for B = 0.2.
The case without a final payoff term is on the left and the case with a payoff term is
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Figure 2.9: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and controls m = m(x, t) without
(on left) and with (on right) an integral constraint
on the right. With a higher cost on the control, the maximum control rate, M = 1,
is never applied. As before, the presence of the final payoff term does impact the
R
state. The final time population size, Ω u(x, T ) dx is 0.1719 when there is no final
payoff term compared to 0.2272 when there is a final payoff term. The values for the
objective functional at the optimal control for the two cases are 0.1606 for A = 0 and
0.2584 for A = 0.5.
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Figure 2.10: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and controls m = m(x, t) (on
left) and m = m(x) (on right), both with an integral constraint

2.8

Conclusions

We have considered the problem of optimal resource allocation for a diffusive
population with logistic growth. Optimal resource allocation will maximize the total
population over time and space including a final time population abundance goal,
while minimizing the associated costs for control. We have established the existence
and uniqueness of the solution to the state system given a control and we have
established the existence of an optimal control. We derived necessary conditions for an
optimal pair giving rise to an optimality system consisting of the coupled state-adjoint
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Figure 2.11: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and controls m = m(x) without
(on left) and with (on right) an integral constraint
system and the characterization of the optimal control. Further, for sufficiently small
values of final time T we have demonstrated uniqueness of the optimal control.
Some numerical simulations have been given to demonstrate possible scenarios.
We show results for a one dimensional domain that compare Neumann and Dirichlet
boundary conditions with various initial conditions as well as various final times
and maximum control values for the case where m = m(x, t). In particular, we
showed that it makes sense to invest more on allocating resources for a population
not subject to an inhospitable boundary. In the case of an inhospitable boundary, it
makes sense to invest more for population densities that are further away from the
inhospitable boundary than for population densities that are near the inhospitable
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Figure 2.12: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and controls m = m(x, t) without
(on left) and with (on right) a final time payoff with weight coefficient A = 0.5
boundary. Furthermore, an optimal control will “drive” population densities that are
near an inhospitable boundary toward the center of the domain, away from the hostile
boundary.
For Neumann boundary conditions, we have shown a range of comparisons for
controls that vary in space and time or controls that vary only in space, for controls
with and without an integral constraint, and for objective functionals with and
without a final time payoff term. We showed how varying the final time can impact
the optimal control. With more time, more control is applied early in the time domain
compared to the same interval of time for the case with less time. Ecologically, it is
worthwhile to invest more in resources if there is more time to allocate them.
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Figure 2.13: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and controls m = m(x) without
(on left) and with (on right) a final time payoff with weight coefficient A = 0.5 and
cost coefficient B = 0.05
We also showed how an optimal control that can vary in both time and space
achieves a higher objective functional value than an optimal control that can vary
in space only. The value of the objective functional decreases further under an
integral constraint on the control. Furthermore, we showed that under an integral
constraint, control is applied early (if m = m(x, t)) and less control is applied where
the population concentrations are small than in the case with no integral constraint.
Under the same integral constraint, we showed that a control that can only vary in
space achieves a smaller overall population abundance. Finally, we showed the impact
of a final time payoff term on both the optimal control and its corresponding state.
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Figure 2.14: Optimal control and corresponding states for Neumann boundary
conditions with initial condition shown in Figure 2.1 and controls m = m(x) without
(on left) and with (on right) a final time payoff with weight coefficient A = 0.5 and
cost coefficient B = 0.2
There are several questions we are currently investigating that extend these results.
In particular, we are considering populations with dynamics that are subject to
diffusion varying in space and time as well as advection. We are also considering two
dimensional habitats and ecologically more realistic initial conditions for numerical
simulations as well as scenario-specific parameter values in our model and for our
objective functional.
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Chapter 3
Antimicrobial Stewardship for the
Control of Clostridium difficile
Transmission in Healthcare
Settings
3.1

Introduction

Healthcare-associated infections (HAI) are a very significant problem in the U.S.
health care system, exacting a severe cost in both lives and dollars (U.S. Department
of Health and Human Services, 2013). The most common cause of HAI in the U.S. is
the enteric pathogen, Clostridium difficile (Lessa et al., 2015). Clostridium difficile is
an important nosocomial enteric, spore-forming bacillus (Leffler and Lamont, 2015).
Clostridium difficile infection (CDI) can be acquired in healthcare settings as well
in the community (Steiner et al., 2012). In particular, C difficile accounts for up to
20% of nosocomial antibiotic associated diarrhea and is the primary cause antibioticassociated colitis (Bartlett, 2002). In 2011, the number of infections was estimated
to be about 500,000 and the number of deaths linked to the pathogen was estimated
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at 29,000 (Lessa et al., 2015). The incidence of CDI in the U.S. healthcare system
continues to rise. The rate of discharges in which the patient received the diagnosis of
CDI more than doubled from 2001 to 2010 (Steiner et al., 2012). The cost attributable
to CDI in U.S. acute care facilities is estimated to be as much as $4.8 billion per year
(Dubberke and Olsen, 2012).
CDI prevention measures have not changed sufficiently to manage these rising
numbers. The focus of these measures is on testing symptomatic patients in order
to identify patients with CDI so that isolation and contact precautions can be taken
(Cohen et al., 2010; Dubberke et al., 2008). Recent studies, however, point out the
significance to transmission within the ward of both transmission pathways beyond
the ward itself and additional sources of CDI infections (Dubberke et al., 2014).
Successful control measures will come only with a better understanding of C. difficile
transmission.
Mathematical models have been developed to describe nosocomial transmission;
these studies, in particular, used ordinary differential equations (ODEs) to model the
transmission dynamics (Brauer, 2015; Webb et al., 2004; Yahdi et al., 2012; Hsieh
et al., 2014). In a study closely related to our work, Lanzas et al. (2011) developed
and analyzed an ODE model for C. difficile transmission within a medical ward. A
threshold value for within ward transmission assuming no admission of colonized or
diseased individuals was calculated. One may think of this as the relative contribution
of the hospital ward itself to transmission with respect to some larger population.
For about half of the parameter space domain, this threshold value is less than one.
That is to say that in the absence of the admission of colonized and diseased patients,
the basic reproductive number, R0 , is less than one. The basic reproductive number
in this case is defined as the average number of secondary infections caused by the
introduction of a single infected individual into a disease free hospital. Nosocomial
colonizations of C. difficile cannot, therefore, be sustained solely by transmission due
to diseased patients. The role of asymptomatic carriers, for example, is significant to
within-ward transmission. Lanzas and Dubberke (2014) developed an agent-based
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model (ABM) to study the effectiveness of identifying asymptomatic carriers by
screening upon admission in reducing the incidence of CDI. Sources of transmission
heterogeneity such as the admission of colonized and undetected diseased patients
are significant in sustaining nosocomial transmission. A better understanding of
transmission, therefore, requires a better understanding of the patients’ pre-admission
history with respect to factors pertinent to CDI and how these factors contribute to
within-ward transmission.
Another important source of nosocomial transmission heterogeneity is environmental heterogeneity (Dubberke et al., 2008; Gerding et al., 2008). The risk of a
susceptible patient becoming colonized by C. difficile depends significantly on the
local pathogen contamination level (Dubberke et al., 2014). Healthcare workers
are an important vector of transmission and, so, the scope of their interactions
with patients represents a local pathogen contamination level (McMaster-Baxter and
Musher, 2007; Donskey, 2010). The level of contamination in one hospital ward,
for example, may vary significantly from that of another ward in the same hospital.
One important control measure that addresses local contamination levels is to place
symptomatic patients under quarantine in order for contact precautions to be initiated
that decrease the environmental bioburden associated with diarrhea (Gerding et al.,
2008).

Cleaning and disinfection of the environment are also important control

measure for reducing local contamination levels (Gerding et al., 2008).
Antibiotic treatments in hospitals provide another source of transmission heterogeneity. The fact that Clostridium difficile is resistant to a wide range of antibiotics
allows it to colonize a gut wherein the flora has been altered due to treatment by such
antibiotics (Rupnik et al., 2009). The risk factors associated with different antibiotics
with respect to CDI vary significantly (Slimings and Riley, 2014; Dancer et al., 2013).
Antibiotic stewardship programs are, therefore, important for the prevention and
control of CDI (Feazel et al., 2014; Talpaert et al., 2011).
In this modeling study we will take into account these sources of heterogeneity in
order to better understand transmission and, thereby, more accurately evaluate the
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efficacy of control measures. In particular, our model includes individual patient
characteristics important to pathogen transmission. We also incorporate certain
stochastic effects that are significant to transmission dynamics in small populations
such as a hospital. Agent-based models are well suited to simulate such individual
(or agent) characteristics and behaviors as well as incorporating various stochastic
effects. A recent example relevant to this study is found in D’Agata et al. (2007).
Their ABM considered three processes: admission and discharge of patients, infection
of patients by health-care workers (HCW) and contamination of HCW by patients. It
considered only one individual trait, the bacterial load of infected patients. The goal
of their study was to describe the complexities of the transmission dynamics in order
to “identify the key parameters contributing to the spread of a typical antimicrobial
resistant bacteria in a typical hospital setting.” Notably absent from this work,
however, were important individual patient characteristics such as patient history
that are more important with respect to CDI than for other healthcare-associated
infections. Critically important to within-ward transmission is the precise state of
individual patients with respect to CDI upon admission. Patients who are colonized
upon admission, for example, are a significant source contributing to within-ward
transmission (Curry et al., 2013).
D’Agata et al. (2007) also lacks within-hospital patient history such as when
antibiotic treatment began and what level of risk is associated with this antibiotic.
This is also the case for the ABM found in Codella et al. (2015). The probability
associated with a susceptible patient becoming colonized varies significantly with the
both of these factors and should not be considered constant (Slimings and Riley,
2014; Dancer et al., 2013; Feazel et al., 2014; Talpaert et al., 2011). Not only are
such components important for understanding transmission, they are important for
intervention and control measures.
The ABM model found in Rubin et al. (2013) features several components that are
important for transmission such as patient-HCW interactions, room contamination
and hand hygiene. This study also incorporates antibiotic treatment. It does not,
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however, consider antimicrobial stewardship as a control measure. In an evidencebased systematic review, Hsu et al. (2010) conclude that antimicrobial stewardship
is one of the control measures with the greatest evidence for preventing healthcareassociated CDI and, so, in this study we consider antimicrobial stewardship as a
control measure.
The goal of this study is to evaluate the efficacy of various control measures aimed
at reducing environmental contamination and mitigating the effects of antibiotic use
on transmission for reducing the nosocomial incidence of colonization and infection.
We, therefore, propose and implement an ABM for Clostridium difficile transmission
in hospitals that accounts for several additional processes and individual factors that
are relevant to Clostridium difficile transmission in healthcare settings, including
the environmental and antibiotic heterogeneities discussed above. Environmental
decontamination strategies (Gerding et al., 2008) will result in lower probabilities of
susceptible patients becoming colonized which, in turn, will further contribute to the
decontamination of the environment. We account for local contamination levels in our
ABM which contribute to the probability of colonization. These levels are influenced
in our model by the probability of effective cleaning and this, then, is a control for
modeling environmental decontamination.
There are two basic strategies employed in the implementation of an antimicrobial
stewardship program (Dancer et al., 2013; Feazel et al., 2014; Talpaert et al., 2011;
Gerding et al., 2008). One strategy is to reduce the overall number of antibiotic
prescriptions by some proportion. This will result in a smaller number of susceptible
patients and will lead, therefore, to a smaller number of colonizations. Alternatively,
the relative proportions of antibiotics prescribed by type are changed. In particular,
we are interested in differentiating antibiotics by the level of CDI risk with which they
are associated. This will result in lower probabilities of susceptible patients becoming
colonized. We account for both the number and type of antibiotic treatments given
to patients in our model and thereby they are controls for modeling antimicrobial
stewardship. In order to describe the model in such a way that facilitates replication,
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we use the updated ODD (Overview, Design concepts, Details) protocol described in
Grimm et al. (2010).

3.2
3.2.1

ODD Protocol: Overview
Purpose

We present an agent-based model (ABM) that simulates the transmission of
Clostridium difficile in healthcare settings in order to evaluate the efficacy of various
control measures (e.g. antimicrobial and environmental stewardship) in reducing the
nosocomial incidence of colonization and infection.

3.2.2

Input Data

The model layout and agent behaviors as well as rate parameters and initial conditions
come from published studies as well as previously collected epidemiological data from
Barnes-Jewish Hospital in St. Louis, Missouri. These data are for a retrospective
cohort of 11046 admissions in medicine wards at a large tertiary care hospital, which
included laboratory-confirmed cases of CDI, admission, discharge, and confirmed
laboratory dates, and antimicrobial exposures. Summary data from this set were
provided by Lanzas and further description of these can be found in Lanzas et al.
(2011).
Control measures for reducing nosocomial colonization and infection are model
inputs. The level of contamination is one factor contributing to the probability
of a susceptible patient becoming colonized. We regard effective cleaning to be
cleaning that reduces the contamination level of a ward room (see Section 3.3.6).
The probability that a vacant room will be effectively cleaned (terminal cleaning) is
a global variable. Changing the value of this probability is a control input for the
model representing different cleaning programs.
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Another control strategy of the model is to reduce the overall number of antibiotic
treatments by a certain proportion. This is implemented in the following way. Let q
be the proportion reduction to be implemented. Of all the patients that were assigned
to receive a treatment each half day according to the half-daily probability of receiving
an antibiotic (see Table 3.2), only 1 − q of them will now actually receive a treatment.
Alternatively, one may change the relative proportions of the types of antibiotic
treatments that are prescribed. Each time an antibiotic treatment is prescribed, there
is a probability that it will be low, high, or very-high risk with respect to CDI. The
baseline values for these probabilities were taken from the data and are 0.4, 0.26 and
0.34 respectively (see Table 3.2). These proportions can be changed in accordance
with a specified stewardship program.

3.2.3

Entities, State Variables, and Scales

The model has two kinds of entities: hospital patients and rooms. Individual rooms
are classified by two state variables. A room has a certain level of contamination
– low, medium, or high – and a room either is or is not occupied by a patient
under quarantine. Symptomatic patients are placed in quarantine or isolation for
the purpose of implementing contact precautions that decrease the environmental
bioburden associated with diarrhea (Gerding et al., 2008). While healthcare workers
are not agents of this model, their effect as vectors for disease transmission is implicit
in the fact that ward-level contamination levels contribute to patient colonization.
That is, the probability that a susceptible patient in a particular ward room will
become colonized depends in part on the contamination level of the entire ward. We
regard a hospital ward a reasonable measure of the scope of a healthcare worker’s
interaction with patients.
Patients are classified by several state variables.

These are summarized in

Table 3.1. With respect to Clostridium difficile infection (CDI), a patient can be
resistant to colonization, susceptible to colonization, colonized, or diseased. Each
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patient is assigned a (hospital) length of stay (LOS) and the patient’s time since being
admitted is tracked. The time since a patient’s current disease status is tracked. If
a patient goes on an antibiotic, the time since beginning the antibiotic treatment is
tracked as well as the level of CDI risk associated with the antibiotic with which they
are being treated. This model considers three such levels of risk – low, high, and very
high risk. The number of antibiotics a patient has received during hospitalization is
also tracked. Colonized patients either will or will not mount an immune response.
Those who will not are said to be immunocompromised. Diseased patients either will
or will not be identified as diseased upon screening and those that are treated for the
disease either will or will not be treated successfully.
We here describe the model’s global variables. A summary of these global variables
and their values is given in Table 3.2. The occupancy level for the hospital is a global
variable set to 0.85. The probability of a patient being resistant upon admission is
0.58 while the probability of being diseased upon admission is 0.01. The probability
of being susceptible upon admission is chosen randomly from a uniform distribution
ranging from 0.21 to 0.40. This value will fix the corresponding probability of being
colonized upon admission which will range between 0.01 and 0.20. The probability
that a colonized patient will be immunocompromised is a global variable. The baseline
value for this variable is 0.10. There is a half-daily probability that a susceptible
patient or a colonized patient that is not immunocompromised will regain resistance.
The minimum such probability is a global variable, and its value is 0.2. For a full
description see Section 3.3.4. There is a half-daily probability that a patient will
begin an antibiotic treatment. The baseline value for this variable is 0.27. This
value was chosen so that simulation outputs pertaining to overall number of antibiotic
treatments per patient reflect the hospital dataset. Each time an antibiotic treatment
is prescribed, there is a probability that it will be low, high, or very-high risk with
respect to CDI. The baseline values for these probabilities were taken from the data
and are 0.4, 0.26 and 0.34 respectively. The odds ratio values for high and veryhigh risk antibiotics are global variables and are given by ORh = 4 and ORvh = 8,
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Table 3.1: Description of room and patient variables of the agent based model.
Variable
number-ward-rooms
contamination-status
contamination-quotient
quarantine-patient-here
length-of-stay
time-since-admission
disease-status
time-since-current-status
time-since-began-antib
treatment-length
time-to-normal

antib-risk-level
number-hosp-antibs
immunocompromised
prob-regaining-resistance
prob-becoming-colonized
length-incubation-period

time-until-diseased
will-ID
will-treat-succ

Description
number of rooms per ward
room-level contamination measure
ward-level contamination measure
indicates whether the occupant is under
quarantine
patient’s hospital length of stay
patient’s time since being admitted
patient disease status
patient’s time since their current disease
status
patient’s time since beginning their current
antibiotic treatment
prescribed length of the current antibiotic
treatment
time until patient’s gut flora is considered
normal
low risk:
high risk:
very-high risk:
risk level of the current antibiotic with respect
to CDI
number of hospital antibiotics the patient has
received
indicates if a colonized patient is immunocompromised
probability of regaining resistance to colonization
probability of becoming colonized
length of time between colonization and
becoming diseased by antibiotic risk level
low risk:
high risk:
very-high risk:
time until an immunocompromised, colonized
patient will become diseased
determines whether a particular screening will
correctly test positive for CDI
determines whether a patient will be successfully treated for CDI
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Values
35
0, 1, 2
0, 1, ..., 70
Yes, No
[0, 160]
0, 1, 2, ...
R,S,C,D
0, 1, 2, ...
0, 1, 2, ...
14

28
28
70
low, high,
very-high
0, 1, 2, ...
yes, no
[0, 1]
[0, 1]

[20, 60]
[14, 40]
[8, 20]
[0, 60]
yes, no
yes, no

respectively. For a full description see Section 3.3.8. The half-daily probability of
a susceptible patient becoming colonized given that they are being treated with a
low risk antibiotic in a highly contaminated environment, denoted by ph` , is a global
variable and its value is 0.15. Again, for a full description see Section 3.3.8. Each
time a room is cleaned, there is a probability that it will be cleaned effectively. For a
description of what this means see Section 3.3.6. A baseline value of 0.5 was assigned
to this variable under the simple assumption that different cleaning measures could
be more or less effective at reducing the level of contamination. In our model it
is assumed that patients with CDI are also symptomatic. Once a patient becomes
diseased and, thus, symptomatic, they are screened for CDI. The sensitivity (0.91)
of this test is a global variable as well as the turnover time (2 half-days) for this test
(Planche et al., 2008). When a patient is treated for CDI, there is a probability (0.8)
that the treatment will be successful.
The spatial scale of the model is one hospital consisting of six medical wards,
each containing thirty-five rooms. This is reflective of the hospital from which the
previously described dataset came. In this model we assume that at most one patient
can occupy a room. The time step is one half-day and the temporal extent of the
simulation is one year.

3.2.4

Process Overview and Scheduling

The following process takes place each time step (half-day). Time-tracking characteristics for patients are updated. New patients are admitted, the contamination of the
environment is updated, the patients progress with respect to their infection status,
patients are discharged, and vacant rooms are cleaned.

3.2.5

Initialization

The model hospital is initially populated with patients who have various hospital and
pre-hospital histories with respect to each of the patient variables listed in Table 3.1.
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Table 3.2: Description of global variables of the agent based model.
Variable
occupancy
prob-R

Description
Baseline Value
occupancy level of the hospital
0.85
probability a patient is resistant upon admis0.58
sion
prob-S
probability a patient is susceptible upon
[0.21, 0.40]
admission
prob-C
probability a patient is colonized upon
[0.01, 0.20]
admission
prob-D
probability a patient is diseased upon admis0.01
sion
immcomp-prob probability a colonized patient is immuno0.1
compromised
pmin
minimum probability of regaining resistance
0.2
prob-antib
half-daily probability that a patient will begin
0.27
an antibiotic treatment
prob-low-risk
probability a hospital assigned antibiotic is
0.4
low-risk with respect to CDI
prob-high-risk
probability a hospital assigned antibiotic is
0.26
high-risk with respect to CDI
prob-vhigh-risk probability a hospital assigned antibiotic is
0.34
very high-risk with respect to CDI
ORh
odds ratio value for high risk antibiotics
4
ORvh
odds ratio value for very-high risk antibiotics
8
h
p`
probability of becoming colonized if treated
0.15
with low risk antibiotic in highly contaminated environment
prob-eff-clean
probability of effective cleaning
0.5
sensitivity
sensitivity of the screening test for CDI
0.91
turnover
turnover time for the screening test for CDI
2
prob-succ-treat probability of successful treatment of CDI
0.8
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The occupancy level is a global variable set to 0.85 and is kept constant. The
environment is then initialized (see Section 3.3.3 for details). As the patients from this
initial population are discharged, new patients are admitted. The hospital-history of
these new patients more accurately reflect the processes of the model. In order for
the initial hospital population not to have influence on model outputs, the simulation
runs 200 time steps before recording outputs.

3.3

ODD Protocol: Submodels

This section describes in detail the subroutines that make up the main process.

3.3.1

Update Time Characteristics

Patients’ time since admission and, with one exception, time since current disease
status are updated. For resistant patients, the time since current disease status is
not tracked. This is because the value of this state variable is only relevant for
the progression of patients who are susceptible, colonized or diseased. Unlike them, a
patient who is resistant will remain resistant until and unless they receive an antibiotic
at which time they become susceptible to colonization.
Susceptible patients and colonized patients who are not immunocompromised have
their time since beginning antibiotic treatment updated. Colonized patients who
are immunocompromised have their time until diseased updated. Three classes of
diseased patients are considered here. Those who have been screened successfully but
have not yet reached the turnaround time have their time since screening updated.
The turnaround time for a screening is the time between administering the test and
receiving the results. Those who have been screened unsuccessfully but have not yet
reached the turnaround time also have their time since screening updated. In this
way, they will not be screened again until at least the turnaround time has passed.
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Finally, those who have been screened successfully and have begun treatment have
their time since beginning treatment updated.

3.3.2

Admission

Each time step, a number of patients are admitted. This is referred to as an admission
class. The same number of patients is admitted as were just discharged. This is done
to assure consistency, so that the number of patients to be admitted does not exceed
the number of vacant rooms. Moreover, the number of patients being discharged
varies significantly each time step since it is ultimately based on the patients’ varying
lengths of stay and times since admission.
For each admission class, the probability of a patient being resistant upon
admission is 0.58 while the probability of being diseased upon admission is 0.01
(Lanzas et al., 2011). However, for each admission class, at each time step, the
probability of being susceptible upon admission is chosen randomly from a uniform
distribution ranging from 0.21 to 0.40.

This value will fix the corresponding

probability of being colonized upon admission which will range between 0.01 and
0.20.
Each patient is randomly admitted to a vacant room and their time since admission
is initialized.

They are then assigned a disease status according to the above

probabilities as well as a length of stay based on the hospital dataset. The procedure
for this assignment is described in detail in Section 3.3.10.
Susceptible patients are given an antibiotic history since patients become susceptible to colonization via the disruption of the flora caused by antibiotic treatment.
First, a particular type of antibiotic is assigned according to the treatment length,
time until flora recovery, and the risk level vis à vis CDI associated with this antibiotic.
This procedure is described in Section 3.3.7. Second, a time since beginning antibiotic
treatment is assigned. This is a random integer drawn from a uniform distribution
ranging from 0 to an upper limit defined as the sum of the treatment length (14
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half-days) and time until flora recovery (28 half-days for low and high-risk antibiotic,
70 half-days for very high-risk antibiotic). That is, we regard a patient as susceptible
to colonization from the moment they begin an antibiotic treatment and they can
remain susceptible as long as their gut flora is not normal. Finally, the patient is
assigned a time since becoming susceptible. In this case, it is precisely the time since
they began antibiotic treatment.
Colonized patients either will or will not mount an immune response and
so are characterized as one or the other according the global variable for the
probability that a colonized patient is immunocompromised. Patients who are not
immunocompromised are given an antibiotic history. First, an antibiotic is assigned
in the same way as described above for susceptible patients. Second, a time since
beginning antibiotic treatment is assigned; again, in the same way as for susceptible
patients. Lastly, they are assigned a time since becoming colonized. A patient may
have become colonized at any time since they began antibiotic treatment and, thus,
this variable is assigned a uniform random integer between 0 and the time since they
began treatment.
If the colonized patient is immunocompromised, they will become diseased at a
certain point in time that must be assigned. First, an antibiotic history is assigned.
In this case, what matters most is the risk level associated with their antibiotic
assignment. Next, the length of the incubation period is determined. The incubation
period depends on the risk level associated with their antibiotic assignment. For
each level of antibiotic risk, there is a pair of global values for the minimum and
maximum length of the incubation period. Baseline values for these pairs are (20,60),
(14,40), and (8,20) for low, high, and very high risk antibiotics respectively. A random
integer from a uniform distribution of integers in the appropriate range is assigned
as the length of the incubation period. The patient’s time until becoming diseased is
assigned as a random integer greater than or equal to 0 but less than the incubation
period. The time since current disease status in this case is equal to the length of the
incubation period minus the time until becoming diseased.
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Finally, for patients who are diseased upon admission, it is decided if the initial
screening will be successful in identifying them as diseased according to the global
variable for the sensitivity of the test and it is also decided if treatment will be
successful according the global variable for this probability. The baseline values for
the sensitivity and probability of successful treatment are 0.91 (Planche et al., 2008)
and 0.8 (McFarland, 2008) respectively. Patients who will be identified as diseased
due to successful screening are assigned a time since the successful screen. In this way,
they will be identified when that time reaches the turnaround time for the test. The
baseline value for the turnaround is 2 half-days (Planche et al., 2008). At that point
the patient will be quarantined and treatment will begin as described in Section 3.3.9.
Diseased patients who are unsuccessfully screened will not be tested again until after
the turnaround time for the test and so are assigned a time since the unsuccessful
screening.

3.3.3

Update Contamination Status

After a class of patients is admitted, the environment is updated. Each room has
a contamination status of clean, contaminated, or very contaminated represented by
the values 0, 1, and 2 respectively. During an update, the contamination status of a
room occupied by a colonized patient is set to 1 while the contamination status of a
room occupied by a diseased patient is set to 2. This value is affected by the cleaning
procedure (Section 3.3.6).
The ward-level contamination is the sum of the contamination status values of all
the rooms in the same ward. Since each ward has 35 rooms, each with a maximum
contamination value of 2, this will be an integer between 0 and 70.

This sum

excludes the contamination values of those rooms that contain a quarantined patient.
Thus, our model assumes that quarantine is 100% effective. This does not effect,
however, the uncertain level of cleaning the room will receive upon the discharge of
the quarantined patient. This value will be used in determining the probability that
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a susceptible patient will become colonized (Section 3.3.8). While healthcare workers
are not agents of this model, their effect as vectors for disease transmission is implicit
in the fact that ward-level contamination levels contribute to patient colonization.
That is, the probability that a susceptible patient in a particular ward room will
become colonized depends in part on the contamination level of the entire ward. We
regard a hospital ward a reasonable measure of the scope of a healthcare worker’s
interaction with patients. Therefore, the contamination level of the ward, rather
than that of the individual patient room, contributes to the probability of becoming
colonized.

3.3.4

Update Disease Status

Each half-day there is a probability that a patient will begin an antibiotic treatmenteven if they are currently being treated with antibiotics. This model parameter
was chosen so that simulation outputs pertaining to overall number of antibiotic
treatments per patient reflect the hospital dataset. One of the model control strategies
is to reduce the overall number of treatments by a certain proportion.

This is

implemented in the following way. Of all the patients that were assigned to receive a
treatment each half day according to the probability just described, only a proportion
of them will now actually receive a treatment.
The transitions described in this section are illustrated by the diagram in
Figure 3.1. If a resistant patient goes on an antibiotic, they become susceptible
and an antibiotic is assigned. The time since beginning antibiotic and time since
current disease status are set to 0. A new length of stay is selected for this patient
according the new disease status. If it is longer than the patient’s current length of
stay, then the patient’s length of stay is changed to this value.
Each half-day, there is a probability that a susceptible patient will regain
resistance. This probability is a logistic function of the time since they began their
most recent antibiotic treatment. In particular, let t be the time since the patient
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Figure 3.1: Disease state transitions for CDI
began antibiotic treatment and let T be the sum of the treatment length and the
associated time until a normal flora is restored. Then, the probability, p, of regaining
resistance is given by
p=

1 − pmin
+ pmin ,
12
T
1 + e−( T (t− 2 ))

where pmin = 0.2 is the minimum probability of regaining resistance and the
parameter value 12 determines the steepness of the logistic curve.
If they do not regain resistance, there is a probability they will receive an
additional antibiotic as described above. Then, there is a probability they will become
colonized (Section 3.3.8). If they do become colonized, they are designated as either
immunocompromised or not according to the global variable for the probability of
being immunocompromised. If the now colonized patient is immunocompromised,
then an incubation period is assigned as before. This value determines when they will
become diseased. Furthermore, the number of nosocomial colonizations is tracked.
Similar to susceptible patients, colonized patients who will mount an immune
response can regain resistance. If they do not regain resistance, there is a chance
they will receive an additional antibiotic; this is also the case for those patients who
will not mount an immune response. For these patients, if their incubation period
is over, they become diseased. If that happens, they will be screened at the next
time step (because they are now symptomatic) and it is determined if the screening
will be successful in identifying them as diseased according to the global variable for
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sensitivity. It is also decided if the subsequent treatment will be successful according
the global variable for this probability. The number of nosocomial diseases is tracked.
A diseased patient is quarantined and treatment is begun (Section 3.3.9) if they
have been identified; that is, if they were successfully screened and they have reached
the turnaround time. A diseased patient who has not been identified as diseased is
re-screened if the turnover time since the unsuccessful screening has been reached.
Diseased patients that have completed a successful treatment become susceptible.

3.3.5

Discharge Patients

Patients are discharged if their length-of-stay variable is the same value as their timesince-admission variable. The current disease status, disease status at admission and
the number of antibiotics received during their stay are tallied for each discharged
patient.

3.3.6

Cleaning

After a patient is discharged, the vacant room is cleaned.

If the room has

contamination status 2 or 1, then there is a probability that cleaning will result
in a new contamination status of 1 or 0, respectively. The probability of effective
cleaning is a global variable. A baseline value of 0.5 was assigned to this variable
under the simple assumption that different cleaning measures could be more or less
effective at reducing the level of contamination.

3.3.7

Antibiotic Assignment

When a patient goes on an antibiotic, there is a probability that it will be low,
high, or very high-risk with respect to CDI. There is a treatment length and time to
normal flora associated with each class. The risk level is one factor in determining
the probability of being colonized.
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3.3.8

Assign Probability of Becoming Colonized

The half-daily probability of a susceptible patient becoming colonized depends on
both the local, ward-level environment and the risk level associated with the antibiotic
they are receiving.
The environment is classified as low, medium, or high contamination. These
classifications are determined by the typical range and variance of ward-level
contamination values for the simulations of this model.
The probabilities associated with different antibiotic risk levels (see Section 3.3.7)
are determined using odds ratios. The odds ratio (OR) of interest in this case is
a measure of the association between an exposure to antibiotic treatment and the
outcome of becoming colonized by C. difficile. Studies have identified the odds ratios
for colonization risk assigned to specific antibiotics (Bignardi, 1998; Feazel et al., 2014;
Slimings and Riley, 2014). In our model, the OR represents the odds that a patient
will become colonized if they have been given a high or very high risk antibiotic,
compared to the odds of becoming colonized when given a low risk antibiotic. These
are global variables in the model.
Let p be the half-daily probability of a susceptible patient becoming colonized
given that they are being treated with a low risk antibiotic. In general, we can use
p together with a known odds ratio value associated with a particular antibiotic to
find the half daily probability of the patient becoming colonized given they are being
treated with that particular antibiotic. Let ORA be the odds ratio associated with
antibiotic A and let pA be the half daily probability of the patient becoming colonized
given they are being treated with antibiotic A. Then the relationship
ORA =

pA . p
,
1 − pA 1 − p

implies
pA =

ORA · p
.
1 − p + ORA · p

79

Odds ratio values for the categories “high risk” and “very-high risk” are based
on the odds ratio values for the individual antibiotics in these categories (Bignardi,
1998; Feazel et al., 2014; Slimings and Riley, 2014) as well as information from the
hospital dataset regarding the relative proportion of the number of treatments for each
specific antibiotic to the overall number of antibiotic treatments. For each category, a
weighted average was calculated using the odds ratio values for each specific antibiotic
in the category and the corresponding number of these treatments from the hospital
dataset. In this way, we estimated the odds ratio values for high and very-high risk
antibiotics to be ORh = 4 and ORvh = 8, respectively.
Since there is also an environmental component to colonization, we will have
half-daily probabilities for each of the 9 combinations from the 3 environmental
contamination levels and the 3 antibiotic risk categories; see Table 3.3. Let ph` be
the half-daily probability of a susceptible patient becoming colonized given that they
are being treated with a low risk antibiotic in a highly contaminated environment.
Here the subscript, `, refers to the risk level associated with the antibiotic and stands
for “low”. The superscript, h, refers to the level of ward contamination and stands
for “high”. Table 3.3 indicates the values for each of the 9 combinations and how
they are calculated.
First a value is assigned to ph` . The value 0.15 for ph` was chosen by calibration to
match the proportion of nosocomial colonizations from the data. From this value and
the values for ORh and ORvh , we calculate the other two probabilities for a highly
contaminated environment, phh and phvh . Next, we calculate the probability, p`` , of a
susceptible patient becoming colonized given that they are being treated with a low
risk antibiotic in a low contamination environment. We do this by scaling down by
a certain factor, q: p`` = q · ph` . This factor is a measure of the relative contribution
of the environment to the colonization of a susceptible patient. For the simulations
we assigned the value 0.5 to the factor q. The other two probabilities for a low
contamination environment are then calculated similar to above. Finally, we take pm
`
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Table 3.3: Global variables for the half-daily probabilities of becoming colonized.
Variable
ph`

Antibiotic risk
Low

Level of contamination
High

Value
= 0.15

phh

High

High

ORh · ph`

phvh

Very high

High

ORvh · ph`

p``

Low

Low

p`h

High

Low

ORh · p``

p`vh

Very high

Low

ORvh · p``

pm
`

Low

Medium

pm
h

High

Medium

pm
vh

Very high

Medium

h
. p`

1 − ph` + ORh · ph`

.

1 − ph` + ORvh · ph`

q ·.ph` = 0.5 · 0.15

1 − p`` + ORh · p``

.






1 − p`` + ORvh · p``



h
`
.(p` + p` )/2
m
ORh · pm
(1 − pm
`
` + ORh · p` )
.
m
ORvh · pm
(1 − pm
`
` + ORvh · p` )

to be the average of p`` and ph` and from this calculate the other two probabilities for
a medium contamination environment.

3.3.9

Quarantine and Treat

In this model, quarantined means that the contamination level of their room does not
contribute to the overall ward-level contamination. This models the effect of isolation
and contact precautions that decrease the environmental bioburden associated with
diarrhea (Gerding et al., 2008). When a patient is quarantined due to CDI, they begin
treatment for CDI. This means they will be assigned an antibiotic (Section 3.3.7) and
the time since beginning treatment is initialized.

3.3.10

Length of Stay

Patients are assigned a length of stay upon admission according to their disease
status. This half-daily value is assigned by resampling summary data from the
hospital dataset. In particular, given a patient’s disease status, their length of stay is
assigned by resampling from the relevant histogram generated by the length of stay
data for patients with that disease status. The range of the values for the length
of stay in half-days for resistant, susceptible, and diseased patients are [0, 32], [0, 68]
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and [0, 160], respectively. The range for colonized patients is the same as that for
susceptible patients.

3.4

Control Strategies

The control measures considered in this study are antimicrobial stewardship and
decontamination by cleaning.

There are two basic strategies employed in the

implementation of an antimicrobial stewardship program.
One strategy is to reduce the overall number of antibiotic prescriptions by some
proportion. Here we consider three values for such reduction, 0, 0.1, and 0.2, where no
reduction is considered the baseline value. Let qr be the reduction proportion. This
reduction is achieved in the model by first deciding whether a patient would receive
an antibiotic according to the global variable prob-antib with value 0.27 (Table 3.2),
and then, if they were to receive one in the situation with no reduction, there is now
a probability of 1 − qr that they will receive an antibiotic.
Alternatively, rather than reducing the number of prescriptions, the relative
proportions of antibiotics prescribed by type are changed. In particular, we are
interested in differentiating antibiotics by the level of CDI risk with which they are
associated. As described in Section 3.3.7, there are three categories of risk in this
model, ‘low’, ‘high’, and ‘very high.’ We consider three scenarios. The baseline
scenario, established from the hospital dataset, has the proportions 0.4, 0.26, and
0.34 for ‘low’, ‘high’, and ‘very high’ respectively. For a second scenario, we consider
replacing half of the very high risk prescriptions with high risk antibiotics. The
corresponding proportions for this scenario are 0.4, 0.43, and 0.17. Finally, in addition
to replacing half of the very high risk prescriptions with high risk antibiotics, we also
replace half of the high risk prescriptions with low risk antibiotics. The resulting
proportions for this scenario are 0.53, 0.3, and 0.17. These scenarios are summarized
in Table 3.4.
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Table 3.4: Antibiotic risk proportion scenarios.
Scenario
1
2
3

Proportion low-risk
0.4
0.4
0.53

Proportion high-risk
0.26
0.43
0.3

Proportion very high-risk
0.34
0.17
0.17

As described in Section 3.3.6, there is a global variable in the model assigning a
probability of effective cleaning. We select three values for this variable to represent
the effect of certain levels of the effectiveness of a cleaning strategy. A baseline value of
0.5 was assigned to this variable under the simple assumption that different cleaning
measures could be more or less effective at reducing the level of contamination.
Accordingly, the other two values considered are 0.2 and 0.8.

3.5

Simulation Results for Stewardship Strategies

A complete factorial design for the combination of these three strategies with each of
their respective three scenarios was implemented. The 27 strategies are summarized
in Table 3.5. One hundred runs were completed for each strategy. In the figures to
follow, the combination strategy will be referred to by its corresponding number in this
table. Note that combination strategy number 2 is the baseline scenario. Recall that
the baseline scenario is the scenario that corresponds to the data set used to design
the model (see Section 3.2.2) and reflects current strategies for controlling disease
transmission. Strategy number 2 reflects no reduction in the number of antibiotic
treatments given and, so, the baseline value for the proportion reduction is 0. The
relative proportions of treatments from the hospital dataset that were low, high, and
very-high risk with respect to CDI are 0.4, 0.26 and 0.34 respectively. These are,
therefore, the baseline risk-scenario. Finally, as described above, the baseline value
for effective cleaning, 0.5 was chosen in order to compare strategies that are both
more effective and less effective in this regard.
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Table 3.5: Numbering of combination strategies.
Combination
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27

Proportion reduction
0
0
0
0
0
0
0
0
0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2

Risk-scenario
1
1
1
2
2
2
3
3
3
1
1
1
2
2
2
3
3
3
1
1
1
2
2
2
3
3
3

Probability of effective cleaning
0.2
0.5
0.8
0.2
0.5
0.8
0.2
0.5
0.8
0.2
0.5
0.8
0.2
0.5
0.8
0.2
0.5
0.8
0.2
0.5
0.8
0.2
0.5
0.8
0.2
0.5
0.8

The outputs to measure the relative effectiveness of these strategies were the
incidence numbers of nosocomial colonizations and diseases per year, while the total
number of admissions per year is 10,458 on average. In the box plots shown in
Figure 3.2, the 27 combined strategies are ranked according to their respective median
values of nosocomial colonizations. These median values are indicated by the circles
with dots in the center. The top chart contains box plots for the number of new
colonizations by strategy and they are plotted in increasing order by median values.
The bottom chart indicates the corresponding box plots for the number of new
diseases.
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Figure 3.2: Box plots for strategies ranked by number of new colonizations at top
and corresponding box plots for number of new diseases on bottom
Note, for example, the rank of the baseline scenario, scenario 2. There are 6
scenarios that, on average, resulted in more new colonizations. As one would expect,
each of these 6 scenarios (19, 7, 13, 10, 4, 1) are cases where the probability of effective
cleaning is less than the baseline value for this probability. Recall that the baseline
value for this probability is 0.5 and in the 6 scenarios it is 0.2. It is worth pointing out,
however, that there are 3 scenarios (16, 22, 25) with probability 0.2 of effective cleaning
that, on average, resulted in fewer new colonizations. For scenario 22, the median
number of new colonizations is 6261 which is 4% less than the 6525 colonizations for
the baseline scenario. Scenario 16 results in 5% fewer colonizations. In scenario 25,
however, the median number of new colonizations was 5756 compared to the baseline
median value of 6525, which is a 12% reduction. The strategy implemented in scenario
25 involved both a reduction in overall antibiotic treatments as well as a reduction
in the relative proportions of antibiotic treatments that are high and very-high risk
with respect to CDI. This suggests that it is possible for an aggressive antibiotic
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stewardship strategy reduce the number of new colonizations even in the event of less
effective cleaning.
The bottom chart in Figure 3.2 shows the corresponding numbers of nosocomial
diseases. These numbers do not necessarily increase respectively by scenario to the
numbers of new colonizations. As noted above, compared to the baseline scenario,
the reduction in new colonizations for scenario 22 was modest compared to that for
scenario 25: 4% compared to 12%. The corresponding comparison of these scenarios
for the reduction in new diseases is much closer: 23% compared to 29%. The only
difference between these two strategies is that scenario 22 represents risk-scenario
number 2 while scenario 25 represents risk-scenario number 3 (see Table 3.4). This
suggests that there are strategies that may be similarly effective with respect to
reducing the number of nosocomial colonizations but differ significantly in terms of
reducing nosocomial diseases.

Figure 3.3: Box plots for strategies ranked by number of new diseases on bottom
and corresponding box plots for number of new colonizations on top
In Figure 3.3, the 27 combined strategies are ranked according to their respective
median values of nosocomial diseases. The bottom chart contains box plots for the
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number of new diseases by strategy and they are plotted in increasing order by median
values. The top chart indicates the corresponding box plots for the number of new
colonizations. By this ranking there are only 3 scenarios that, on average, resulted
in more new diseases than the baseline scenario. And, again, each of these 3 are
scenarios where the probability of effective cleaning is less than that of the baseline
scenario. There are, therefore, 6 scenarios in which the probability of effective cleaning
is less than that of the baseline scenario and, yet, are more effective in reducing the
number of new diseases. Of these, scenario 25 represents the largest reduction and
was discussed above as having 29% less disease incidence than the baseline scenario.

Figure 3.4: Box plots for strategies 4 and 21 for numbers of new colonizations on
top and new diseases on bottom
What stands out when ranked according to the number of new diseases is the
corresponding change in the number of new colonizations. In particular, we note a
significant change in the number of new colonizations between scenarios 4 and 21
(see Figure 3.4). The median numbers of new diseases for these two scenarios are
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close to the same, 152 and 157 respectively. The median number, 7137, of new
colonizations represented by scenario 4 is, however, 39% more than the 5124 new
colonizations represented by scenario 21. The strategy for scenario 4 involves no
reduction in the overall proportion of antibiotic treatments but it does represent
stewardship of the relative proportions of treatments according to risk using risk
scenario 2 (see Table 3.4). Scenario 21, on the other hand, does not implement
a stewardship of risk proportions, but, rather, it implements an overall reduction
in the number of treatments and a more effective cleaning strategy. This suggests
that there are strategies that may be similarly effective with respect to reducing the
number of nosocomial diseases but differ significantly in terms of reducing nosocomial
colonizations. In terms of policy, it is important to consider strategies the efficacy of
which are evaluated in terms of reducing both nosocomial diseases and colonizations.
One important consequence of ignoring the reduction of nosocomial colonizations is
that many of these individuals will develop the disease after leaving the hospital. This
will inevitably lead to an increase in the admission rate of diseased patients (Otten
et al., 2010).
Suppose one wants to implement only one of the three strategies and wants to know
the relative efficacy of one strategy over another in reducing nosocomial colonizations
and/or diseases. Table 3.6 summarizes the relevant values from our simulations for
making this evaluation. From this perspective, the best single strategy to implement
is one that reduces both the relative proportion of antibiotic treatments that are high
risk with respect to CDI and the relative proportion of antibiotic treatments that
are very-high risk with respect to CDI. Table 3.6 indicates that this strategy does
the best in terms of reducing nosocomial colonizations and it also does the best in
terms of reducing nosocomial diseases. The median number of new colonizations for
this strategy is 5424 which is 17% less than the baseline number of new colonizations
which is 6525. The median number of new diseases for this strategy is 128 which is
29% less than the baseline number of new diseases which is 181. In fact, in terms of
reducing nosocomial diseases, the other strategy in this category ranks 2nd , with 141
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new diseases which is 22% less than the baseline. This is the strategy that reduces the
relative proportion of antibiotic treatments that are very-high risk with respect to CDI
but does not reduce the relative proportion of antibiotic treatments that are high risk
with respect to CDI. If the more aggressive strategy is unrealizable or, perhaps, too
expensive, then one might choose the same type of, but less aggressive, stewardship
policy. This would be, however, another example of ignoring the value of reducing the
number of nosocomial colonizations. Notice that this strategy, while ranking 2nd with
respect to reducing the number of diseases, ranks 5th with respect to reducing the
number of colonizations; only slightly better than the baseline scenario. Once again,
it is important for policies to consider strategies that are effective in reducing both
nosocomial diseases and colonizations. If one wishes to take into account both goals
(and the more aggressive strategy is not available), then the next best strategy is the
other type of stewardship policy that reduces the overall number of treatments by
20%. This highlights the importance of understanding the complexities of Clostridium
difficile transmission in order to make the best decisions with respect to implementing
control measures.
Table 3.6: Median colonizations and diseases for employing a single strategy
Parameter
to vary
Probability of
effective cleaning
Risk-scenario
Table 3.4
Proportion
reduction

3.6

Parameter
value
0.2
0.8
2
3
0.1
0.2
Baseline:

Median
colonizations
7376
5988
6109
5424
6024
5498
6525

Median
diseases
196
176
141
128
174
165
181

Rank by
colonizations
7
3
5
1
4
2
6

Rank by
diseases
7
5
2
1
4
3
6

Conclusions

In this study we have pointed out the significance to nosocomial transmission
of Clostridium difficile of important sources, including the role of asymptomatic
89

carriers, environmental heterogeneity, and the complex role of antibiotic treatments
in hospitals.
We implemented an ABM for Clostridium difficile transmission in hospitals
that accounts for several processes and individual factors including environmental
and antibiotic heterogeneity in order to evaluate the efficacy of various control
measures aimed at reducing environmental contamination and mitigating the effects
of antibiotic use on transmission. In particular, we accounted for local contamination
levels in our ABM which contribute to the probability of colonization. These levels
are influenced in our model by the probability of effective cleaning and, so, served as
a control for modeling environmental decontamination. We also accounted for both
the number and type of antibiotic treatments given to patients in our model and, so,
served as controls for modeling antimicrobial stewardship.
Our model showed that it is possible for an aggressive antibiotic stewardship
strategy to reduce the number of new colonizations even in the event of less effective
cleaning. We showed that there are strategies that may be similarly effective with
respect to reducing the number of nosocomial colonizations but differ significantly in
terms of reducing nosocomial diseases. We showed that there are, likewise, strategies
that may be similarly effective with respect to reducing the number of nosocomial
diseases but differ significantly in terms of reducing nosocomial colonizations.
In an evidence-based systematic review, Hsu et al. (2010), seek to identify
and critically evaluate the efficacy of interventions for the prevention of CDI in
healthcare institutions. Corroborating our modeling results, this study concludes that
there is good evidence to support the effectiveness of antimicrobial stewardship for
preventing healthcare-associated CDI. While this study does address, for example, the
ineffectiveness of treating asymptomatic carriers for preventing healthcare-associated
CDI, it does not consider the prevention of colonization as an important metric
for making such an evaluation. Our modeling study suggests, however, that it is
important for policy makers to consider strategies that are effective in reducing both
nosocomial diseases and colonizations. An important consequence of ignoring the
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reduction of nosocomial colonizations is that many of these individuals will develop
the disease after leaving the hospital which, in turn, can lead to an increase in the
admission rate of diseased patients. We have shown, therefore, the importance of not
evaluating the efficacy of a strategy based solely on its success in reducing nosocomial
diseases.
We also considered the situation wherein one implements only one of the three
strategies for the control of Clostridium difficile transmission. We showed the relative
efficacy of one strategy over another in reducing nosocomial colonizations and/or
diseases. Another example illustrates that choosing a strategy for the goal of reducing
nosocomial diseases does not necessarily achieve the the same relative success for
the goal of reducing nosocomial colonizations. This is an important oversight since
discharging more patients who are colonized by Clostridium difficile will lead to more
individuals that develop the disease after leaving the hospital. This will inevitably
lead to an increase in the admission rate of diseased patients.
The agent-based model presented here is a useful tool for investigating strategies
for reducing the overall Clostridium difficile burden in healthcare settings. In the
future, we plan to design simulations for evaluating management strategies that
are connected to current practices in order to predict their expected impact on
Clostridium difficile burden. For example, an aggressive antimicrobial stewardship
policy may be difficult to implement and will likely be influenced by both the needs
of patients and the actual pathogens involved. Our model can easily incorporate the
compliance habits of healthcare workers and can be adapted to other hospital datasets
and management protocols.
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